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Abstract 
 
Malaria is one of the most deadly parasitic diseases known to man. Although the number of 
malaria cases reported each year is decreasing, this disease continues to pose health and 
economic problems mainly in developing countries. Significant progress has been made in 
the fight against this disease. This includes the discovery and development of potent 
antimalarial agents. However, the development of resistance to most of these potent 
antimalarials has made the development of new antiplasmodial agents of paramount 
importance. 
 
Several promising antiplasmodial agents have been found from the marine environment. 
Amongst these are the tetraprenylated toluquinols from the brown alga: Sargassum 
heterophyllum. These metabolites have been reported to exhibit a range of antiplasmodial 
activity; however, the mechanisms by which these compounds bring about their 
antiplasmodial activity and the pharmacophoric groups responsible for such activity are 
unknown.  
 
Two species of Sargassum algae were encountered during the course of this project. From the 
investigation of the geographical and seasonal variation of metabolites of S. heterophyllum 
and S. elegans we established that there were no significant intra and inter site variations 
amongst metabolite profiles of both species both within and between the sampled seasons. 
These results enabled us to establish that the collection of both species from three different 
sites on the eastern coast of South Africa namely; Kenton on Sea, Port Alfred and Noordhoek 
in autumn, winter or spring would qualitatively yield the same metabolites. A comparison of 
metabolite profiles of both species also revealed no qualitative differences between 
metabolites of S. heterophyllum and S. elegans.  
 
The quantities of selected prenylated metabolites extracted  from S. heterophyllum  using  
four different extraction techniques was also assessed using qNMR as the method of 
quantification. This led to the identification of optimal extraction techniques and conditions 
for the extraction of sargahydroquinoic acid (1.38), sargaquinoic aid (1.39) and 
sargachromenol (2.10) from S. heterophyllum. From this study, the extraction of algae by 
Abstract 
 
 
xv 
 
soxhlet extraction using EtOH as the extraction solvent led to the extraction of the highest 
quantities of sargahydroquinoic acid. The potential of other extraction techniques such as 
microwave assisted extraction, to yield high quantities of the selected metabolites were also 
identified. 
 
With gram quantities of sargahydroquinoic acid (1.38) in hand, this compound was modified 
by oxidation, reduction, acetylation, methylation and cyclization reactions to yield nine 
derivatives. The derivatives and four naturally occurring prenylated toluquinols were 
assessed for antiplasmodial and cytotoxic activity against the FCR-3 Gambian Chloroquine 
resistant strain of P. falciparum and the MDA-MB-231 breast carcinoma cell line 
respectively. Comparison of antiplasmodial data for all twelve compounds showed that the 
hydroquinone moeity of sargahydroquinoic acid (1.38) is important for antiplasmodial 
activity while esterification of the carboxylic acid group in 1.38 resulted in more potent 
antiplasmodial compounds. Of all twelve compounds, compound 5.2, the hydroquinone 
methyl ester of 1.38 was found to be the most potent antiplasmodial compound with an IC50 
value of 1.94 μM and a selectivity index of 22.68. 
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Chapter 1 
Literature Review 
1.1 Malaria 
Parasitic diseases such as malaria, leishmaniasis, trypanosomiasis, giardiasis and amebiasis 
are prevalent throughout the world (Mancini et al., 2009). Malaria is one of the most deadly 
of these diseases (Mancini et al., 2009; Ravichandran et al., 2007). This disease is caused by 
four strains of the Plasmodium parasite namely P. falciparum, P. vivax, P. ovale and P. 
malariae (Williams and Lemke, 2002; Balint, 2005). Of these parasites, Plasmodium 
falciparum causes the most virulent form of disease in humans (Williams and Lemke, 2002). 
In 2009, 225 million cases of malaria were reported (World Health Organisation, 2010b). Of 
these cases, an estimated 781,000 deaths, mostly amongst children in Africa, were also 
recorded (World Health Organisation, 2010b). From the 106 countries in which malaria is 
endemic, countries in Sub-Saharan Africa are amongst the most widely affected (World 
Health Organisation, 2010b; Laurent and Pietra, 2006).
 
Apart from adversely affecting human 
health and contributing to childhood mortality, malaria also decreases gross domestic 
productivity in countries in which it is endemic (Laurent and Pietra, 2006; Chima et al., 
2003). 
 
1.1.1 Control of Malaria 
The control of malaria is dependent on various forms of chemotherapy with a higher 
emphasis on drug therapy compared to the use of malaria prophylaxis (Olliaro, 2001). 
Presently, drugs from different classes are used to treat malaria (World Health Organisation, 
2010a). The selection these agents is dependent on several factors including patterns of 
parasite resistance to antimalarial agents in the relevant area (World Health Organisation, 
2010a). 
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Figure 1.1 Map showing countries or areas in which the transmission of malaria occurs 
 (World Health Organisation, 2011b) 
 
1.1.1.1 Commonly used antimalarial agents 
Currently used antimalarial agents target different stages of the Plasmodium parasite’s life 
cycle (figure 1.2). The folate antagonists inhibit the synthesis of essential nucleotides 
(Olliaro, 2001).
 
By mimicking the substrate: para-amino benzoic acid (PABA) the 
sulphonamide folate antagonists; sulfadoxine (1.1), sulfalene  and dapsone  inhibit the 
enzyme dihydropteroate synthase (DHPS) (Olliaro, 2001).
 
Other folate antagonists such as 
pyrimethamine (1.2) and the biguanides: proguanil (1.3) and chlorproguanil exert their 
antiplasmodial activity by competing with natural substrates for the active site of 
dehydrofolate reductase (DHFR), another enzyme involved in the synthesis of folates in the 
parasite. In this manner, the folate antagonists are able to target all stages of the asexual cycle 
as nucleotides are essential for development throughout the parasite’s lifecycle (Olliaro, 
2001). Atovaquone (1.4) is structurally classified as a naphthoquinone antimalarial. The only 
one in this class of compounds, this agent acts mainly on the mitochondrial functions of the 
parasite (Olliaro, 2001). Like other antimalarials, several mechanisms by which this agent 
exerts its activity have been proposed. The most widely accepted hypothesis is that 
atovaquone selectively inhibits electron transport in the mitochondrial membrane, resulting in 
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parasite death (Srivastava et al., 1997). Despite the relatively unique mode of action 
displayed by this agent, its use in monotherapy readily leads to parasite resistance (Olliaro, 
2001). Atovaquone is thus used in combination with proguanil, a folate antagonist with which 
it has a synergistic effect (Olliaro, 2001; Mather et al., 2005).  
 
 
Figure 1.2 Plasmodium life cycle showing the phases targeted by specific antimalarial agents 
 (Olliaro, 2001; Michalakis and Renaud, 2009) 
 
The quinoline group of antimalarial compounds contains the most commonly known 
antimalarial agents. This class of antimalarial agents is made up of the 4-amino-quinolines 
such as chloroquine (1.5), amodiaquine (1.6)  and piperaquine (1.7), the amino alcohols: 
quinidine (1.8), quinine (1.9), mefloquine (1.10), halofantrine (1.11) and lumefantrine in 
addition to primaquine (1.12), an 8-amino-quinoline (Olliaro, 2001). The most widely 
accepted mode of action for this class of compounds is that they act by targeting the 
parasite’s disposal of haem in the intra erythrocytic asexual stage of the parasite’s life cycle 
(Foote and Cowman, 1994). During the blood stages of its lifecycle, the parasite accumulates 
haem from the host’s red blood cells. The accumulation and exposure of this substance to the 
parasite’s cells is toxic, hence the parasite sequesters haem into a membrane bound food 
vacuole in which the haem is broken down by various mechanisms (Foote and Cowman, 
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1994; Olliaro, 2001). The quinolines are weak bases which are neutral at physiological pH 
and protonated at more acidic pH levels (Foote and Cowman, 1994). These compounds 
readily enter the food vacuole at physiological pH. Upon entry into the relatively acidic food 
vacuole, the quinolines become ionised with 4-aminoquinolines such as chloroquine 
becoming diprotonated (Foote and Cowman, 1994). The quinolines thus lose their ability to 
cross the membrane and accumulate in the vacuole where they interfere with the breakdown 
of toxic haem which in turn accumulates, resulting in the lyses of parasite cell components 
(Olliaro, 2001). Chloroquine in its diprotonated state exerts this effect by inhibiting haem 
polymerase, an enzyme responsible for the detoxification of haem in the parasite (Foote and 
Cowman, 1994). 
The artemisinins (1.13-1.17) also target the detoxification of haem in the parasite lifecycle,
 
killing both the asexual parasite stages in the blood as well as young gametocytes (Olliaro, 
2001; White, 2008). It is widely accepted that the artemisinins are activated by the homolytic 
cleavage of their endoperoxide moiety in the presence of Fe
2+
 in the parasite (O'Neill et al., 
2010; Olliaro, 2001). This leads to the formation of free radicals which in turn alkylate 
biomolecules, resulting in parasite death (O'Neill et al., 2010). By killing young gametocytes, 
the artemisinins reduce both the number of circulating parasites and the number of parasites 
that develop and mature. In this manner, the artemisinins rapidly reduce parasitaemia 
compared to other agents such as quinine which target mature parasites (White, 2008). Other 
agents such as the antibiotics: azithromycin, clindamycin, tetracyline, and doxycycline (1.18) 
are also used in the treatment of malaria (Williams and Lemke, 2002). 
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Figure 1.3 Some of the currently used antimalarial agents  
 (World Health Organisation, 2010b; Williams and Lemke, 2002) 
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1.1.2 The discovery and development of important antimalarial agents 
Most antimalarial agents have been available for a long time (Olliaro, 2001). The first 
compound documented to be used as an antimalarial agent was quinine (1.9) (Talisuna et al., 
2004). This compound, which was extracted from the bark of the cinchona tree was used to 
treat malaria from as early as 1632 (Talisuna et al., 2004). Quinine and its stereoisomer; 
quinidine, were finally isolated and identified by
 
French chemists in 1820 (Greenwood, 
2001). Quinine was still the only known antimalarial by the 19
th
 century, however, its use as 
an antimalarial agent was followed by the first synthetic antimalarials; primaquine (1.12) and 
quinacrine which were produced after 1918 (Talisuna et al., 2004). 
The synthesis of chloroquine (1.5) in 1934 and its development for use as an antimalarial 
agent after the Second World War (1945) was an important milestone in the treatment of 
malaria (Greenwood, 1995; Greenwood, 2001). 
 
Due to its superior antiplasmodial activity, 
this agent went on to replace agents used before it in the treatment of malaria (Greenwood, 
1995; Greenwood, 2001). In addition to this, chloroquine was found to be highly effective, 
with good absorption, distribution and safety profiles with the added advantage of being 
relatively inexpensive (Williams and Lemke, 2002). Unfortunately, the use of this agent was 
hampered by the development and spread of plasmodial resistance to it in 1960 (Olliaro, 
2001; Greenwood, 1995).
 
Although this marked another step backwards in the fight against 
this disease, the emergence of chloroquine resistance was followed by the discovery of  
potent antimalarial compounds from the extracts of the sweet wormwood; Artemisia annua, 
by a group of Chinese Scientists in the 1970’s (White, 2008). The most potent of these 
compounds was characterised, identified and announced to the world as artemisinin (1.13) in 
1979. Despite the fact that the active component of A. annua was identified in the late 1970’s 
the use of an aqueous infusion of this plant as a tea, had been documented as treatment for 
non-specific chills and fevers in China since the 16
th
 century (White, 2008; Cui and Su, 
2009). The discovery of artemisinin; which has been described as one of the most potent and 
effective antiplasmodial agent to be discovered, led to the synthesis of several analogues of 
this compound (Balint, 2005). The use of artemisinin has been widely replaced by some of its 
more potent derivatives such as dihydroartemisinin (1.14), artesunate (1.15) and artemether  
(1.16) (White et al., 1999). The artemisinins were found to be superior to other antimalarial 
agents due to their higher potency, more rapid onset of action in addition to  lower toxicity 
profiles when compared to other antimalarial agents (White et al., 1999; Balint, 2005). 
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The use of artemisinin derivatives in combination with other anti-malarial agents in 
artemisinin-based combination therapy was initially introduced in an effort to delay the 
development of parasitic resistance to the artemisinin derivatives (O'Neill et al., 2010). 
However, the emergence of plasmodial resistance to these agents has been documented at the 
Thai-Cambodian border - a historic region for this disease with the first signs of P. 
falciparum resistance to chloroquine being documented there (O'Neill et al., 2010; Talisuna 
et al., 2004; World Health Organisation, 2010b). The loss of the artemisinin group of 
antimalarial agents to parasite resistance could severely hamper global progress against 
malaria (World Health Organisation, 2011a). In addition to this, the highly adaptive nature, 
complex life cycle and large genome of the Plasmodium parasite has resulted in significant 
challenges in the successful development of a vaccine against malaria (Ravichandran et al., 
2007; Plowe et al., 2009). However, recent reports of a malaria vaccine, RTSS/A0S2A that 
has proved to be safe and efficacious in phase I and II b clinical trials have emerged (Sacarlal 
et al., 2009). The fact that there is no registered vaccine against malaria despite longstanding 
efforts to develop one and the potential loss of the artemisinin derived antimalarials to 
resistance makes the development of new chemotherapeutic agents for this disease, of 
paramount importance (Ziegler et al., 2002; Laurent and Pietra, 2006; Kreidenweiss et al., 
2006). 
 
1.1.3 Natural products in the treatment of malaria 
Natural products have played an essential part in drug discovery and development, especially 
in the treatment of malaria (Mancini et al., 2009). This is illustrated by the emergence of 
significant antiplasmodial agents from natural sources such as quinine (1.9) and artemisinin 
(1.13) (Wright et al., 1996). In addition to this, many of the currently used antimalarial agents 
are based on compounds from natural sources (Ziegler et al., 2002; Laurent and Pietra, 2006). 
Following the synthesis of chloroquine and the development of resistance to it, the discovery 
of artemisinin resulted in a renewed interest in the screening of natural sources for 
antimalarial agents (Laurent and Pietra, 2006).
 
This serves to highlight the fact that the 
chemical diversity in biological systems is important in the identification and development of 
lead compounds for this disease (Ziegler et al., 2002). The marine environment has shown 
itself to be a rich source of numerous chemical entities of novel and distinct chemotypes, 
many of which have not been reported from the terrestrial environment (Paterson and 
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Findlay, 2008; Donia and Hamann, 2003). Although the marine environment has been less 
studied compared to the terrestrial environment, it has the potential to provide lead 
compounds for use as antiplasmodial agents (Donia and Hamann, 2003; Paterson and 
Findlay, 2008; Young-Won Chin et al., 2006; Faulkner, 2000a). 
 
1.2 The Marine environment 
The marine environment displays great diversity in terms of both the living organisms which 
inhabit it and in the range of secondary metabolites that they produce (Ravichandran et al., 
2007; Pomponi, 1999).
 
Compared to the biodiversity displayed amongst terrestrial organisms, 
the marine environment has the greatest biodiversity (Donia and Hamann, 2003). Recorded as 
the habitat of 34 of the 36 phyla of all living organisms, this environment, has over 300,000 
described species of plants and animals (Pomponi, 1999; Ravichandran et al., 2007). The 
adaptation of these marine organisms to the harsh conditions of this environment has resulted 
in the production of an array of chemical defence strategies to enable their survival (Ham et 
al., 2010; Park et al., 2008; Ravichandran et al., 2007; Paterson and Findlay, 2008).
 
These 
chemical defences; seen as secondary metabolites have presented natural products chemists 
with a collection of unique compounds that display a wide range of biological activities and 
potential medicinal applications (Ham et al., 2010; Park et al., 2008).  
As diseases continue to develop, evolve and present unending challenges for scientists, the 
marine environment provides a fertile ground for the discovery of potential medicinal agents 
(Donia and Hamann, 2003). The possible uses of these isolated metabolites has fuelled an 
interest in compounds of marine origin (Blunt et al., 2010; Faulkner, 2000b). Since the 
identification of the first natural products from marine organisms, chemists have been 
intrigued by compounds which display vast structural and complex diversity isolated from 
this environment (Lane and Moore, 2011). The marine environment has thus far yielded a 
registered drug, Ziconotide, the synthetic version of a ω-conotoxin  peptide isolated from the 
venom of the cone snail Conus magnus (Young-Won Chin et al., 2006). This compound is  
used in the treatment of chronic pain (Young-Won Chin et al., 2006). Despite the fact that not 
many compounds of marine origin have resulted in registered pharmaceutical products, 
several compounds of marine origin such as compounds 1.19- 1.26 (figure 1.3), have entered 
clinical trials; mainly for the treatment of cancer, while others have provided lead compounds 
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for new drug candidates (Faulkner, 2000a; Donia and Hamann, 2003; Butler, 2005; Young-
Won Chin et al., 2006). 
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Figure 1.4 Marine derived bioactive compounds from natural products that have either 
 entered in clinical trials or provided lead compounds for new drugs (Donia and 
 Hamann, 2003; Faulkner, 2000c; Konig et al., 2006; Butler, 2005) 
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1.2.1 Antiplasmodial agents from the marine environment 
Several compounds of marine origin have been identified as potential antiplasmodial agents 
(Ravichandran et al., 2007; Wright et al., 1996). Kalihinol A (1.27) from a sponge of the  
Acanthella species (Miyaoka et al., 1998) as well as plakortins such as dihydroplakortin 
(1.28) isolated from Plakortis simplex are amongst some of these metabolites (Fattorusso et 
al., 2002). A group of alkaloids known as the manzamines have been isolated from several 
sponges of the Pellina, Pachypellina, Xestospongia, Ircina, and Amphimedon species. The 
manzamines have shown significant antiplasmodial activity (Ang et al., 2000). Of these 
secondary metabolites, manzamine A (1.29) has been described as the most promising 
compound possesing antiplasmodial activity to be isolated from the marine environment 
(Ang et al., 2000; Mendiola et al., 2006; Wright et al., 1996). Thus far, the complete synthesis 
of manzamine A has been reported (Wright et al., 1996). From the marine red alga Laurencia 
papillosa, two aromatic compounds, p-hydroxy benzaldehyde (1.30) and p-methoxybenzyl 
alcohol (1.31) have been isolated (Wright et al., 1996). Of these compounds, p-hydroxyl 
benzaldehyde was reported to have antiplasmodial activity (Wright et al., 1996). Despite the 
fact that the activity of this compound was relatively weak compared to other compounds 
from the same organism, it had good selectivity for the Plasmodium parasite (Wright et al., 
1996). The sponge Acanthella clethra has also yielded several metabolites with unique 
structures and good antiplasmodial activity (Gross and Konig, 2006). Of these metabolites, 
axisonitrile-3 (1.32) and diisocyanoadociane (1.33) have been shown to exhibit the most 
potent activity (Gross and Konig, 2006; Wright et al., 1996). The main advantages of these 
compounds over the rest of the metabolites are the high activity and low cytotoxic profile of 
axisonitrile-3 and  the greater antiplasmodial activity of  diisocyanoadociane despite its high 
cytotoxic activity (Angerhofer et al., 1992; Gross and Konig, 2006).
 
Two phloeodictynes 1.34 
and 1.35 with good antiplasmodial activity and selectivity indices have also been reported 
from the Caledonian sponge; Phloeodictyon sp (Mancini et al., 2004; Laurent and Pietra, 
2006). Since the discovery of the antiplasmodial potential of these compounds, the total 
synthesis of some of the phloeodictynes has been reported (Laurent and Pietra, 2006).  
Metabolites from marine microorganisms have also provided potential antiplasmodial agents 
(Wright, 2005; Wright and Lang-Unnasch, 2005). The screening of several metabolites from 
marine fungi afforded the identification of  6R,12R,14R-colletoketol  (1.36) isolated from  
Varicosporina ramulosa, a fungus derived from brown algae of the genus Cystoseira as well 
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as pycnidione  (1.37) which was isolated from fungi of the Phoma species (Wright and Lang-
Unnasch, 2005; Holler, 1999). Results from this screening showed that marine products of 
fungal origin are a potential source of antimalarial lead compounds and that structural 
modification of these metabolites could result in an increase in antiplasmodial activity 
accompanied by a decrease in the cytotoxicity profiles of these metabolites (Wright and 
Lang-Unnasch, 2005). 
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 Four compounds from Sargassum heterophyllum have been reported to exhibit 
antiplasmodial activity (Afolayan et al., 2008). These compounds are sargahydroquinoic acid 
(1.38), sargaquinoic acid (1.39), sargaquinal (1.40) and fucoxanthin (1.41) (Afolayan et al., 
2008). Of these metabolites, fucoxanthin and sargaquinal showed good antiplasmodial 
activity with IC50 values of 1.5 µM  and 2.0 µM respectively, while sargaquinoic acid and 
sargahydroquinoic acid were found to possess moderate antiplasmodial activity with IC50 
values of 12.0 µM  and 15.2 µM respectively against the D10 chloroquine sensitive strain of 
Plasmodium falciparum (Afolayan et al., 2008).
 
The mechanisms by which these compounds 
bring about their antiplasmodial activity and the pharmacophoric groups responsible for such 
activity are unknown. In addition to this, the activity of these compounds against chloroquine 
resistant strains of P. falciparum is still to be established. 
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1.3 Research objectives 
The main aim of this research project was to synthesise several substituted derivatives of the 
tetraprenylated toluhydroquinone, sargahydroquinoic acid (1.38) using the natural product as 
the starting material. This was done in an effort to identify the pharmacophoric groups 
responsible for the antiplasmodial activity of the tetraprenylated toluquinones from S. 
heterophyllum.  
In addition to this, the project aimed to: 
i. Determine the most appropriate time and site for the collection of S. heterophyllum 
ii. Determine the most efficient extraction technique for the extraction of selected 
tetraprenylated metabolites from S. heterophyllum 
iii. Isolate sufficient quantities of sargahydroquinoic acid to enable the chemical 
modification of this compound  
iv. Assess the antiplasmodial activity of the synthesized derivatives against a 
chloroquine resistant strain of Plasmodium falciparum 
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Chapter 2 
 
Extraction and Isolation of Tetraprenylated Toluquinones and 
Fucoxanthin from Sargassum heterophyllum 
 
2.1 Introduction 
 
Macro-algae produce a variety of secondary metabolites, the natural functions of which have 
been widely investigated (Hellio et al., 2004; da Gama et al., 2002). Findings from these 
investigative studies have shown that secondary metabolites play a role in chemical 
mediation as a defence mechanism against herbivores and microorganisms in their immediate 
environment (Simpson, 1987; Hellio et al., 2004; Da Gama et al., 2002; Hay et al., 1987; Paul 
and Van Alstyne, 1992; Kato  et al., 1975). 
 
In the past, secondary metabolites have been 
regarded to be ‘waste products’ of living organisms with no specific functions (Verpoorte, 
1998; Croteau et al., 2000). However, increasing evidence into the varying roles of these 
compounds has been extensively presented. Despite this previous opinion on secondary 
metabolites, organic chemists have studied the chemical properties of these phytochemicals 
from as early as the 1850s (Maplestone et al., 1992; Stone and Williams, 1992; Da Gama et 
al., 2002). 
 
 
2.1.1 Sargassum species 
 
Sargassum species are a species of algae occurring widely in warm and temperate waters of 
tropical and sub-tropical oceans (Dar A et al., 2007; Gillespie and Critchley, 1999). 
Comprising of 150 species, Sargassum species, commonly known as gulf-weed or sea holly 
belong to the order Fucales, subclass Cyclosporeae and class Phaeophyceae (Dar A et al., 
2007). The chemical composition of Sargassum species has been studied extensively (Reddy 
and Urban, 2009; Blunt et al., 2008). This has resulted in the isolation of, phloroethols (e.g. 
2.1) (Glombitza et al., 1997), flavanoids (e.g. 2.2), dipeptides (e.g. 2.3), coumarins (e.g. 2.4), 
and sterols (e.g. 2.5) (Harvey and Kennicutt , 1992; Liu et al., 2009). 
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 Figure 2.1 Selected structural classes of metabolites isolated from Sargassum species 
Polyprenylated metabolites such as; fallahydroquinone (2.6), fallaquinone (2.7) and 
fallachromenoic acid (2.8) have been isolated from the Southern Australian alga Sargassum 
fallax  together with the prenylated toluquinones and toluhydroquinone ; sargaquinone (2.9) 
sargahydroquinoic acid (1.38) and sargaquinoic acid (1.39) (figure 2.2) (Reddy and Urban, 
2009). These compounds, are generally composed of a polyprenyl chain connected to a 
hydroquinone ring moiety (Reddy and Urban, 2009) and
 
have been isolated from 
coelenterates, fish, sponges and tunicates, amongst other marine organisms (Jung et al., 2008; 
Jang et al., 2005). Prenylated toluquinones isolated from Sargassum species usually have the 
same structural backbone, differing mainly in the arrangement of substituents in the linear 
terpene moiety (Reddy and Urban, 2009). 
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Figure 2.2 Prenylated metabolites isolated from Sargassum species 
 
We have previously reported on the antiplasmodial activity of prenylated toluquinols from S. 
heterophyllum (Afolayan et al., 2008). The objectives of the research presented in this chapter 
were to:  isolate selected natural products as reference compounds for further studies of their 
antiplasmodial activity and to obtain sufficient amounts of sargahydroquinoic acid (1.38) to 
be used as the starting material for the chemical modification of this compound.  
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2.2 Results and Discussion 
 
2.2.1 Extraction and isolation of compounds 
Specimens of S. heterophyllum (PA071b) were collected from Port Alfred on the south 
eastern coast of South Africa on 21 September 2007. The alga was extracted with MeOH, 
followed by MeOH-CH2Cl2 (1:2). The extracts were pooled and separated into aqueous and 
organic phases by the addition of deionised water. Concentration of the organic phase under 
reduced pressure gave a dark green residue. A portion of this residue was fractionated by 
gradient elution on a silica gel column using solvents of differing compositions of EtOAc and 
Hexane resulting in seven fractions (7A-G). Selected fractions, containing 
1
H NMR signals of 
interest, were further purified by HPLC or silica gel column chromatography to give 
compounds 1.38 to 1.41 in addition to compound 2.10 (scheme 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 - Extraction and Isolation 
 
 
24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.1 Isolation of compounds 1.38, 1.39, 1.40, 1.41 and 2.10 from S. heterophyllum  
 v) Silica gel column chromatography, solvent Hexane: EtOAc (9:1) vi) Normal phase 
 HPLC, Hexane-EtOAc (80:20) vii) Reversed Phase HPLC MeOH: H2O (90:10). 
 
 
 
i) MeOH extract 
ii) MeOH-CH2Cl2 (1:2) extract 
iii) Add H2O 
Aqueous extract CH2Cl2 extract 
iv)Silica column 
(EtOAc-Hexane) 
S. heterophyllum 
Fr 7E     
1.41 
65.2 mg 
 
1.40 
 
1.7mg 
 
1.39 
5mg 
 
1.38 
6.8mg 
 
 
2.10 
2.4mg 
 
Fr 7A 
8.6 mg 
 
Fr 7C 
132 mg 
Fr 7D 
218 mg 
Fr 7G 
49.6 mg 
Fr 7F 
9.7 mg 
Fr 7H  
238 mg 
Fr 7B 
27 mg 
vii) vi) v) 
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2.2.2 Characterization of isolated compounds  
Not surprisingly, the 
1
H NMR spectra of compounds 1.38-1.40 were very similar. Key 
signals in these spectra included aromatic signals between δ 6.50 and δ 6.26 ppm (table 2.1). 
In addition to these signals, all three compounds had more than one signal between δ 5.38 
and δ 5.10 ppm indicating the presence of unsaturated hydrocarbon moieties. The 1H NMR 
spectrum of  compound 1.38  (figure 2.3) showed two aromatic singlets at  6.50 ppm and  δ 
6.46 ppm (H-3 and H-5) along with three groups of olefinic methine triplets at  6.0 ppm (H-
10’), δ 5.27 ppm  (H-2’) and δ 5.1 ppm (H-6’ and  H-14’).  Two methylene signals at  3.29 
ppm (H-1’) and δ 2.58 ppm (H-9’) were also visible in the 1H NMR spectrum of this 
compound. 
 Two key differences between the 
1
H NMR spectra of 1.38 and 1.39 were observed. Firstly, 
the aromatic protons in 1.39 were more deshielded occurring at δ 6.55 and δ 6.47 ppm 
compared to δ 6.50 and δ 6.46 ppm compared in compound 1.38 (figure 2.4). In addition to 
this, the methylene proton signal in 1.38 appeared at δ 3.29 ppm compared to δ 3.13 ppm in 
1.39. The 
13
C NMR spectrum of these two compounds showed a total of 27 carbons with 
three carbonyl signals for 1.39 occurring at δ 188.8, δ 187.9 and δ 172.7 ppm while that of 
compound 1.38 revealed only one carbonyl signal carbonyl signal at δ 172.4 ppm (figure 2.5). 
The carbonyl signals at δ 172 ppm in both compounds were characteristic of a carboxylic 
acid moiety while the other carbonyl functional groups in 1.39 corresponded to those found 
in benzoquinones. Comparison of spectral data for these compounds with that of metabolites 
previously isolated from Sargassum species in literature allowed for the identification of 
these compounds as sargahydroquinoic acid (1.38) and sargaquinoic acid (1.39). Both these 
metabolites have been previously isolated from S. heterophyllum (Afolayan et al., 2008) and 
S. thunbergii (Seo et al., 2004) amongst other species of the Sargassum genus. 
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Figure 2.3 
1
H NMR spectrum of compound 1.38 (400 MHz, CDCl3) 
 
Figure 2.4 
1
H NMR spectrum of compound 1.39 (400 MHz, CDCl3) 
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Figure 2.5 
13
C NMR spectrum of compound 1.39 (400 MHz, CDCl3) with the insert showing 
 an expansion of the region between δ 188.6 and δ 187.4 ppm 
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Table 2.1 
1
H and 
13
C NMR (400 and 100 MHz) data for compounds 1.38, 1.39, 1.40 and 2.10 
 recorded in CDCl3. 
                         1.38                                         1.39                               1.40                       2.10 
Carbon 
no. 
    δC     δH,  
mult, JHz 
   δC    δH,  
mult, JHz 
  δC    δH, 
mult, JHz 
   δC     δH,  
mult, JHz 
1 146.4  188  187.96  145.6   
2 125.5   145.9   145.9   121.3   
3 115.4 6.50, br s 133.1 6.55, s 132.3 6.54, s 110.3 6.32, d, 2.5 
4 148.7   187.9   187.91   148.5   
5 113.9 6.46, br s 132.2 6.47, s 132.1 6.43, s 117.1 6.47 ,d, 2.4 
6 127.6   148.5   148.4   126.3   
7 16.1 2.18, s 17.7 2.06, m 16 1.67 15.7 2.13, s 
1’ 29.9 3.29 , d, 
6.90 
27.5 3.13, d,  
7.3 
27.3 3.12, d, 
7.2 
122.9 6.26, s 
2’ 121.7 5.27, t, 6.47 117.9 5.12, dt 118.2 5.10, dt, 
6.8 
130.7 5.57, d, 9.8 
3’ 138.2   139.8   139.9   77.8   
4’ 39.5 2.07, m 39.6 2.08, m 39.5 2.06, m  40.8 1.68, s 
5’ 26.0 2.11, m 26.3 2.09, m 26.4 2.06, m 22.6 2.06, m 
6’ 124.2 5.10, d , 
6.70 
124.5 5.12, m 125.5 5.10, dt, 
6.8 
124.9 5.12, dt, 19, 
6.4 
7’ 134.7   134.6   133.6   134.3   
8’ 39.0 2.07, m 39 2.09, m 39.4 2.24, m 39.1 2.06, m 
9’ 28.3 2.58, q, 7.0 28.2 2.59, q, 
7.5 
27.5 2.06, m 28.1 2.59, q, 7.3 
10’ 145.5 6.00, t, 6.90 145.4 6.00, t, 
7.2 
154.9 5.38, m 144.9 5.98, t, 7.2 
11’ 130.5   130.6   132.1   130.5   
12’ 34.5 2.26, t , 7.1 34.5 2.26, t 27.3 2.06, m 34.5 2.27, t, 7.4 
13’ 27.8 2.11, m 27.9 2.11, m 25.7 1.67, s 27.9 2.13, s 
14’ 123.4 5.10, d, 6.70 123.4 5.12, m 123.6 5.10, t, 
6.8 
123.4 5.12, dt, 19, 
6.4 
15’ 132.3   132.2   133.2   132.3   
16’ 25.7 1.68, s 25.6 1.67, s 25.2 1.67, s 25.7 1.68, s 
17’ 17.7 1.58, s 16.1 1.58, s 17.7 1.57, s 17.7 1.58, s 
18’ 172.4  172.7  205.4 9.55, s  172.9   
19’ 16.0 1.59, br s 16 1.60, s 16 1.62, s 15.5 1.58, s 
20’ 16.1 1.75, s 16.1 1.62, s 16.1 1.62, s 25.9 1.68, m 
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The 
1
H NMR spectrum of compound 1.40 was similar to that of sargaquinoic acid (1.39), 
except for the presence of a signal at  9.55 ppm. This signal, characteristic of an aldehyde 
was confirmed by the presence of a carbonyl signal at δC 205.4 ppm in the 
13
C NMR 
spectrum of this compound (table 2.1). Compound 1.40 was identified as 2’E, 6’E, 10’E - 
sargaquinal, a compound that has been previously isolated from S. heterophyllum (Afolayan 
et al., 2008) and S. serratifolium (Kusumi et al., 1979).  
There are discrepancies between the 
13
C NMR data for 2’E, 6’E, 10’E - sargaquinal reported 
by Afolayan et al., and the data reported herein. The chemical shift of C-11’ has been 
reported to resonate at δ 143.2 ppm by Afolayan et al., while this carbon resonates at δ 132.1 
ppm in this study. The previously reported chemical shift for this carbon seems anomalous as 
the carbon atoms at the same position in other compounds of this series; namely 
sargahydroquinoic acid (1.38) and sargaquinoic acid (1.39) resonate between δ 130.5 and δ 
132.1 ppm. In addition to this, the aldehyde signal (C-18’) reported by Afolayan et al., 
resonates at δ 195.1 ppm while the same signal in compound 1.40 is at  δ 205.4 ppm. As a 
result of this, there are differences in the 
1
H NMR data due to the aldehyde signal (H-18’), 
with Afolayan et al., reporting the resonance of H-18’ at δ 9.33 ppm while this proton is 
observed to resonate at δ 9.55 ppm in the present study. Unfortunately, the second reference 
in which 2’E, 6’E, 10’E - sargaquinal has been reported (Kusumi et al., 1979) does not 
contain 
13
C NMR data and conclusive 
1
H NMR data for this compound. To this effect none 
of these discrepancies affect the double bond geometry of this compound 
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Figure 2.6 
1
H NMR spectrum of compound 1.40 (400 MHz, CDCl3) 
 
The 
13
C NMR spectrum of compound 2.10 showed that it had the same number of carbons as 
compounds 1.38-1.40 with signals indicative of both the carboxylic acid (δ 172.9 ppm) and 
an aromatic ring (δ 148.5 ppm and δ 145.6 ppm) (table 2.1). However, the 1H NMR spectrum 
of compound 2.10 was different to that of compounds 1.38-1.40. While the two aromatic 
singlets were still present at  6.32 ppm (H-3) and δ 6.47 ppm (H-5) one of the olefinic 
triplets and the benzylic methylene at  3.29 ppm (H-1’) had disappeared (figure 2.7).  
Instead, two new, mutually coupled olefinic signals at  6.26 (H-1’) and  5.57 ppm (H-2’) 
were apparent. A comparison of NMR spectral data for compound 2.10 with spectral data of 
the chromenols previously isolated from Sargassum species led to the identification of 
compound 2.10 as sargachromenol. This compound has been previously isolated from S. 
micracanthum (Ham et al., 2010). 
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Figure 2.7 
1
H NMR spectrum of compound 2.10 (400 MHz, CDCl3) 
 
The 
1
H NMR spectrum of 2.41 (figure 2.8) was different from the spectra of compounds 
1.38, 1.39, 1.40 and 2.10. It was characterised by a distinct doublet at δ 7.15 ppm in addition 
to a group of signals between δ 6.78 and δ 6.05 ppm. The 13C NMR spectrum of this 
compound presented a set of resonances in different regions compared to those observed in 
compounds 1.38, 1.39, 1.40 and 2.10 (table 2.2). This, together with the fact that 42 
resonances in the 
13
C NMR spectrum of 2.14 as opposed to the 27 resonances observed in 
compounds 1.38, 1.39, 1.40 and 2.10 suggested that this molecule was of a different 
structural class (table 2.2). Comparison of 
1
H  and 
13
C NMR data of this compound to other 
known compounds that had been previously isolated from S. heterophyllum (Afolayan et al., 
2008) allowed for the positive identification of 1.41 as fucoxanthin. 
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Figure 2.8 
1
H NMR spectrum of 1.41 (400 MHz, CDCl3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HO
O
C
O
HO
O
O
1.41 
Chapter 2 - Extraction and Isolation 
 
 
33 
 
Table 2.2 
1
H and 
13
C NMR (400 and 100 MHz, CDCl3) data for compound 1.41 
Position No. C                   δH Carbon No. C                   δH 
1 35.76   11 123.36 6.54 
1’ 35.14  11’ 125.66 6.58 
2 47.1  12 144.99 6.66 
2’ 45.43 1.48 12’ 137.1 6.33 
3 64.3 3.82 13 135.4  
3’ 68 5.37 13’ 18.05  
4 41.65 1.73 14 136.6 6.39 
4’ 45.23 1.51 14’ 132.15 6.25 
5 66.12  15 129.4 6.63 
5’ 72.67  15’ 132.47 6.75 
6 67.08  16 25.03 1.03 
6’ 117.53  16’ 21.36 1.81 
7 40.8 2.58 17 28.1 0.96 
7’ 202.34 3.63 17’ 32.06 1.07 
8 197.84  18 21.14 1.22 
8’ 103.38 6.05 18’ 31.26 1.35 
9 134.54  19 11.8 1.94 
9’ 132.47  19’ 13.99 1.81 
10 139.1 7.13 20 12.74 1.99 
10’ 128.5 6.11 20’ 12.89 1.99 
 
The purification of the CH2Cl2 extract of S. heterophyllum yielded five distinct compounds. 
All these compounds have been identified as metabolites occurring in Sargassum species. 
Sargachromenol (2.10) has also been isolated from the fruit of a terrestrial Amazonian tree 
Iryanthera juruensis (Myristicaceae) (Silva et al., 2001). Most of the metabolites isolated and 
characterised in this study were polyprenylated toluquinones, with the metabolite of highest 
abundance being the tetraprenylated toluhydroquinone; sargahydroquinoic acid (1.38). The 
presence of these compounds in Sargassum species is expected, as algae in the order; Fucales 
are known to produce phenolic compounds as their most dominant secondary metabolites 
which may amount to up to 30% of the algal dry mass (Plouguerne  et al., 2006). During the 
purification of metabolite 1.38 we observed its slow oxidation to 1.39, its benzoquinone 
analogue. In addition to this we also observed the conversion of 1.39 to 2.10 (scheme 2.2). 
This in vitro transformation of hydroquinones into quinones which are in-turn converted to 
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chromanols in Sargassum metabolites has been reported in the literature literature (Perez-
Castorena et al., 2002; Kusumi et al., 1979). 
 
 
Scheme 2.2 Reaction scheme showing the conversion of sargahydroquinoic acid (1.38) to 
 sargachromenol (2.10) 
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2.3 Experimental 
 
2.3.1 General Experimental 
All extraction solvents were of analytical grade, purchased from commercial suppliers 
(Merck, Germany) and used without further purification. Silica gel (40-63 μm particle size), 
(Merck, Germany) was used for column chromatography. HPLC was carried out on a Waters 
1525 HPLC system fitted with a waters 2487 dual wavelength UV detector set at 254 and 
294nm. Normal Phase HPLC was carried out on a Phenomenex Luna C18 column (10mm × 
250 mm, 10 μm), while a Whatman Partisil 10 semi-preparative column (10mm × 500 mm, 
10 μm) was used for reversed phase HPLC.  NMR spectra were recorded on a Bruker Avance 
400 MHz spectrometer and referenced to CDCl3 solvent signals (
1
Hδ 7.26 and 
13
Cδ 77.0). 
 
2.3.2 Plant Material 
Specimens of S. heterophyllum (PA071b) were collected from Port Alfred on the south east 
coast of South Africa on 21 September 2007. The alga was transported to the laboratory in 
ice and frozen immediately. The samples were authenticated by comparison with voucher 
specimens in the Division of Pharmaceutical Chemistry, Rhodes University, Grahamstown, 
South Africa. The alga was stored at - 4ºC until it was extracted. 
 
 
2.3.3 Extraction and isolation  
 
The frozen alga (38.77 g, extracted dry weight) was allowed to thaw after which it was 
soaked in methanol for one hour. The methanol was removed and the alga immersed in a 
mixture of MeOH- CH2Cl2 (1:2) sufficient to cover it. The alga was then extracted by heating 
at 40°C for 30 minutes. This was repeated twice with solvent of the same composition. 
Extracts were pooled and separated into aqueous and organic phases by the addition of 
deionised water. Concentration of the organic phase under reduced pressure gave a dark 
green residue (3.87 g) whilst the aqueous phase gave a pale green residue (1.16 g). These 
fractions were then analysed by 
1
H NMR. A portion of the organic fraction (1.09 g) was 
fractionated by gradient elution on a silica gel column (10 g) using solvents of differing  
Hexane : EtOAc compositions to give seven fractions as follows : Fr 7A (H:E, 10:0, 8.6mg), 
Fr 7B (H:E, 9:1, 27mg), Fr 7C (H:E , 8:2, 132mg), Fr 7D (H:E, 6:4, 218mg), Fr 7E (H:E, 
4:6,65mg), Fr 7F (H:E, 2:8, 9.7mg) and  Fr 7G (H:E ,0:10, 50mg) followed by MeOH: 
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EtOAc (1:1), Fr 7H (238mg). Some of these fractions were further purified by HPLC or silica 
gel chromatography.  
 
Purification of crude fractions 
Fraction 7B (27 mg).19 mg of this fraction was purified by silica gel column chromatography 
using a system solvent of Hexane: EtOAc (9:1) to give 1.7 mg (8.95% extracted yield) of 
1.40. 
Fraction 7C (132 mg). 40 mg of this fraction was purified by normal phase HPLC, Hexane-
EtOAc (80:20) at a flow rate of 4 ml/min  to give 15 mg (37.5%) of  1.39  with a retention 
time  of 12 min. 
Fraction 7D (218 mg). 20 mg of this fraction was purified by reverse phase HPLC using a 
system solvent of MeOH: H2O (90:10) at a flow rate of 2 ml/min to give compounds 1.38 
(6.8 mg, 34%) and 2.10 (2.4 mg, 12%) with retention times of 12 and19 min respectively. 
Compound 1.41 was characterised from PA071b-7E without further purification.  
 
2.3.4 Compounds 
 
1
H and 
13
C NMR data for sargahydroquinoic acid (1.38), sargaquinoic acid (1.39), 2’E, 6’E, 
10’E – sargaquinal (1.40) and sargachromenol (2.10) – see table 2.1 
 
1
H and 
13
C NMR data for fucoxanthin (1.41) – see table 2.2 
 
Supplementary information 
 
See supplementary information for 2D NMR data for sargahydroquinoic acid (1.38), 2’E, 
6’E, 10’E – sargaquinal (1.41) and sargachromenol (2.10)  
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Chapter 3 
Geographical and Seasonal Variation of S. heterophyllum and S. elegans 
3.1 Introduction 
Secondary metabolites have been reported to vary both quantitatively and qualitatively, even 
within the same species (Kamiya et al., 2010; Plouguerne  et al., 2006; Vallim  et al., 2007). 
 
These variations have been attributed to several factors, some of which have been shown to 
vary geographically, while others have been associated with changes occurring over time 
within the same geographical location (Chennubhotla et al., 1982; Vallim  et al., 2007; 
Targett et al., 1992; Ang, 1984). Such variations have the potential to slow down the search 
for medicinal compounds from natural sources. For the development of lead compounds from 
natural products, it is important to ensure an adequate supply of the natural product. The main 
purpose of this study was to identify the most important factors that may affect the yield of 
sargahydroquinoic acid (1.38) and related metabolites from Sargassum heterophyllum with 
the specific aim of identifying the most suitable site and time for collecting the alga.  
 
3.1.1 Variation of secondary metabolites- a brief overview 
In addition to physical defence mechanisms, marine organisms have also developed chemical 
defence mechanisms against other organisms in their immediate environment (Hellio et al., 
2004). The development of secondary metabolites as a chemical means of anti-fouling is one 
example of these chemical defences (Hellio et al., 2004). The fluctuation of these anti-fouling 
metabolites with varying fouling conditions associated with seasonal changes throughout the 
year has been observed (Hellio et al., 2004; Marechal et al., 2004). In turn, fouling and other 
conditions related to seasonal changes are associated with physical and genetic factors (Hellio 
et al., 2004; Culioli et al., 2002; Marechal et al., 2004; Ursi et al., 2003;Valls and Piovetti, 
1995).
 
Preliminary studies in brown algae have shown geographical and seasonal variation of 
phenolic metabolites in organisms of the same genus (Plouguerne  et al., 2006; Dar et al., 
2007). Seasonal changes in themselves bring about changes in several environmental factors 
such as temperature, pH, salinity, nutrient concentrations and light; which may also vary with 
differing geographical locations (Hellio et al., 2004; Culioli et al., 2002; Marechal et al., 
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2004; Ursi et al., 2003; Valls and Piovetti, 1995).These conditions have an impact on the 
biosynthesis of secondary metabolites (Dar et al., 2007; Chennubhotla et al., 1982).  
 
3.1.2 Taxonomy of the Sargassum Genus  
Six species of the Sargassum genus have been found to occur in South Africa. These include 
S. crassifolium, S. elegans, S. heterophyllum, S. lendigerum, S. longifolium and S. obovatum 
(Seagrief, 1984). This genus has been recorded to be taxonomically complicated as it has a 
divided classification system (Mattio and Payri, 2011; Mattio et al., 2009).There does not 
seem to be an agreement on the number of Sargassum species in the world since Womersley 
(1987) reported 150-200 species, while Yoshida (1989) documented about 500 species and 
most recently Silva (1996) reported 239 species (Yoshida, 1989; Womersley, 1987; Silva et 
al., 1996; Gillespie and Critchley, 2001). Currently, four Sargassum subgenera are 
recognised, these are the subgenera: Arthrophycus, Bactrophycus, Sargassum and 
Phyllotrichia (Mattio and Payri, 2011). These subgenera are further divided into 12 sections 
each with further subdivisions (Mattio and Payri, 2011).
 
In addition to this, Mattio and Payri 
(2011), suggest that the subgenera Arthrophycus and Bactrophycus be merged (with the 
addition of subgenus Arthrophycus to subgenus Bactrophycus) and that subgenus 
Phyllotrichia be transferred to the subgenus Sargassopsis which has recently been reinstated 
(Mattio and Payri, 2011; Draisma et al., 2010). 
 
 
 
3.1.2.1 Classification in the Sargassum Genus 
The classification of Sargassum species is based on several morphological features with 
subgenera being differentiated chiefly by the arrangement of their axes (Mattio and Payri, 
2011). However, the subgenera Bactrophycus and Arthrophycus are distinguished by their 
receptacle morphology (Mattio and Payri, 2011; Yoshida, 1989). Despite this, the 
morphological characteristics used for distinguishing other subdivisions of this genus are not 
clear (Mattio and Payri, 2011). The temporal, intraspecific and intra-geographical variation of 
species within this genus has been identified as the main cause for the taxonomic problems of 
this genus 
 
(Gillespie and Critchley, 2001; Silva et al., 1996). Due to their polymorphic nature 
and phenotypic plasticity, it is possible that current species of this genus have been found 
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synonymous with other species when investigated (Mattio and Payri, 2011).
 
Other reasons for 
the current taxonomical challenges in this genus include possible erroneous identification and 
classification as well as difficulties in retrieving original collected specimens some of which 
may have been accidentally destroyed (Mattio and Payri, 2011; Gillespie and Critchley, 
2001).    
We have commonly encountered two of the Sargassum species occurring on the eastern coast 
of South Africa. These species include S. elegans which belongs to the subgenus Sargassum 
and S. heterophyllum of the subgenus Arthrophycus. S. elegans plants are generally 30-50 cm 
in height, lax and olive-brown in colour, while S. heterophyllum plants are about 50 cm tall, 
coarse, rigid and yellowish in colour with brown streaks when fresh (Stegenga et al., 1997). 
Primary branches of both species are long and can be up to 2 mm in diameter, while foliose 
appendages decrease in size from the stipe to the most distal parts of the alga. These leafy 
appendages are almost linear, attaining sizes up to 5 cm in length and 5 mm in diameter; 
bearing leaves with a distinct midrib and smooth to jaggered edges (Stegenga et al., 1997). 
Members of both species also often have receptacles which may occur in several forms in the 
axils of leafy laterals (Stegenga et al., 1997). The basis of differentiation between these two 
species is their morphological differences (Stegenga et al., 1997). Branches of S. elegans are 
circular in cross section with branched and upright receptacles while the laterals of S. 
heterophyllum are triangular in section with simple, compressed or triangular receptacles. 
Holdfasts are generally small flat and circular for S. elegans plants while they are conical in 
shape in specimens of S. heterophyllum (Stegenga et al., 1997). The chemical composition of 
each of these two species is of particular interest to us, given the taxonomic problems of this 
genus. 
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Figure 3.1a Photograph of S. elegans (adapted from 
 http://www.algaebase.org/search/images/detail/?img_id=12192 .Accessed   
 18/01/2012)  
 
 
 
S. elegans  S. heterophyllum   
Figure 3.1b Diagrams of S. elegans and S. heterophyllum  (Stegenga et al., 1997)    
From the Sargassum species of Southern Africa, it is also clear that there appears to be 
significant variations within species of this genus (Stegenga et al., 1997). Certain 
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morphological differences have been observed in species from differing locations within this 
region. For example, both the significantly dentate leafy appendages of  specimens from 
False Bay on the western coast of  Southern  Africa (figure 3.2) which seldom exceed a 
length three times longer than their width and specimens from the eastern coast of the same 
region; with smooth edged leafy appendages up to 10 times longer than their width, have 
been classified as S. heterophyllum (Stegenga et al., 1997). It is for this reason that Stegenga 
et al., (1997) recommend that S. incisifolim be recognised as the algae found in the western 
cape, while Seagrief (1984) listed S. incisifolium and S.ilicifolium as synonyms for S. 
heterophyllum occurring along the eastern coast of South Africa (Seagrief, 1984). 
 
 
Figure 3.2 Map of South Africa’s coastline (adapted from Seaweeds of the South African 
 West Coast (Stegenga et al., 1997)) 
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Crude extracts of S. heterophyllum and S. elegans were obtained from algae collected at three 
different sites on the eastern cost of South Africa namely: Port Alfred (PA), Noordhoek 
(NDK) and Kenton on Sea (KOS). 
1
H NMR spectra of crude extracts from algae collected at 
each site were evaluated for qualitative differences and compared with each other for both 
intra- and inter-site variation as well as for seasonal variation. Crude extract profiles obtained 
from the different species were also compared. In an effort to eliminate variations in 
extracted metabolites due to the use of different solvents, the selection of extraction solvents 
was evaluated by investigating the types of metabolites extracted by various solvent systems. 
Preliminary investigations of the potential change in metabolite profile between collection 
and extraction were also carried out.  
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3.2 Results and Discussion 
At the outset of this study we recognised that extracts of S. elegans and S. heterophyllum 
were identical. Where possible the two species were collected separately. However, during 
the study we also found that only one of the two species often occurs at specific collection 
sites during specific seasons.   
 
3.2.1 Evaluation of extraction solvents 
Before investigating the geographical and seasonal variation of metabolite profiles, 
preliminary studies to determine the effect of extraction solvents on the metabolite profiles 
were performed. The 
1
H NMR profiles of acetone and EtOH extracts of S. elegans were 
compared to profiles obtained from our standard CH2Cl2- MeOH (2:1) extraction protocol for 
freshly collected algae. Fresh algae were rinsed with deionised water and blotted dry. Stipes 
were separated from the rest of the plant which was then size reduced into fine particles using 
liquid nitrogen and a mortar and pestle. Approximately 2 mL of the size reduced algae was 
placed in a centrifuge tube into which 9 mL of extraction solvent was added. The algae in 
extraction solvent was sonicated for 5 minutes and subsequently centrifuged at high speed for 
5 minutes. 3 mL of the supernatant’s lower layer was collected, concentrated under reduced 
pressure and analyzed by 
1
H NMR spectroscopy.
1
H NMR spectra of S. elegans extracted 
with all three solvent systems did not show major qualitative differences. From the spectra, 
the major metabolites that could be identified were sargahydroquinoic (1.38) and 
sargaquinoic acid (1.39). These metabolites were identified by their signals in the aromatic 
region (figure 3.3). 
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Figure 3.3
 1
H NMR (400 MHz, CDCl3) spectra of crude S. elegans (PA100331) obtained 
 from extraction with different solvents at the site of collection and with CH2Cl2- 
 MeOH (2:1) at the laboratory 
 
 
 
 
 
 
Acetone 
CH2Cl2: MeOH (on site) 
EtOH 
CH2Cl2: MeOH (lab) 
Sargaquinoic acid 
Sargaquinoic acid 
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3.2.2 Investigation of metabolite profile changes between collection site and extraction 
 at the laboratory 
 Possible alterations in the metabolite profiles of S. elegans between collection and 
transportation of algae from the collection site to the laboratory were investigated. S. elegans 
(PA100331) was size reduced as outlined above at the site of collection. From the same 
homogenous mixture of size reduced algae, two portions of approximately 2 mL each were 
placed into two separate centrifuge tubes. One tube was left without solvent while 9 mL of 
CH2Cl2-MeOH (2:1) was placed in another tube. Upon arrival at the laboratory (about 2 
hours later) 9 mL of solvent (CH2Cl2-MeOH (2:1)) was placed into the centrifuge tube 
containing only size reduced algae. Both samples were sonicated for 5 minutes and 
centrifuged at constant speed for another 5 minutes. 3 mL of the liquid extract was withdrawn 
from the supernatant’s lower layer, concentrated under reduced pressure and the crude extract 
analyzed by 
1
H NMR spectroscopy. Spectra of algae extracted with CH2Cl2- MeOH (2:1) 
both at the site of collection and at the laboratory (figure 3.3) were also similar to spectra 
obtained from the preliminary evaluation of extraction solvents. These results led to the 
selection of CH2Cl2-MeOH (2:1) as the solvent of extraction for the rest of the study. These 
results also showed that algae did not undergo any chemical changes during transportation 
between the collection site and the laboratory where it was extracted two hours after 
collection. 
 
3.2.3 Geographical and seasonal variation 
Three collections were undertaken in each season: one in autumn (March), the other in winter 
(July) and the last collection in spring (September). S. heterophyllum was collected from two 
sites while S. elegans was collected from three sites along the eastern coast of South Africa. 
S. heterophyllum collections were made from Noordhoek on the 28
th
 of March and on the 27
th
 
of July and from Port Alfred on the 30
th
 of July and on the 24
th
 of September (Table 3.1). S. 
elegans was collected from Noordhoek on the 28
th
 of March, from Kenton on Sea on the 29
th
 
of March and from Port Alfred on the 31
st
 of March and on the 24
th
 of July. All collections 
were undertaken within 2010. Collections from all three sites were carried out from pools 
which were about 5 m apart; at least two specimens were collected from each pool.  
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To determine the intra-site variation of metabolites within each species, 
1
H NMR profiles of 
specimens collected from different pools at each site within the same month were compared. 
Inter-site variation was assessed by the comparison of 
1
H NMR profiles of the same species 
collected from different sites in the same season. Seasonal variation of metabolites was 
evaluated by comparing metabolite profiles collected at the same site within different months; 
firstly within species and then between species.  
Table 3.1 Summary of collection sites, collected species and dates of collection 
Code Site Month of 
Collection 
Species 
PA100331  PA March S. elegans 
PA100727-11a & 12a PA July S. heterophyllum 
PA100924-9c PA September S. heterophyllum 
PA100924-10c & 11c PA September S. elegans 
NDK100328-4 & 2 NDK March S. heterophyllum 
NDK100328-1 & 5 NDK March S. elegans 
NDK100727-4b NDK July S. heterophyllum 
KOS100329-5 KOS March S. elegans 
 
 
3.2.3.1 Intra- and Inter-site variation 
 
Intra-site variation studies carried out amongst three separate sites in all three seasons i.e at 
PA – in March (figure 3.3), July (figure 3.4 a) and September (figures 3.4 b and c), at NDK in 
March (figures 3.5 a and b) and in July (figure 3.5 c) and at KOS in March (figure 3.6 a), 
yielded identical results for both species.  
 
 
 
 
 
 
Chapter 3 - Geographical and Seasonal Variation 
 
 
50 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 a
 1
H NMR (400 MHz, CDCl3) spectrum of crude S. heterophyllum extracts 
 (PA100727-11a and 12a) collected from different pools at Port Alfred in July 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 b
 1
H NMR (400 MHz, CDCl3) spectra of crude S. heterophyllum extracts 
 (PA100924-9c) collected from different pools at Port Alfred in September 
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Figure 3.4 c 
1
H NMR (400 MHz, CDCl3) spectra of crude S. elegans extracts  
 (PA100924-10c & 11c) collected from different pools at Port Alfred in September 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 a 
1
H NMR (400 MHz, CDCl3) spectra of crude S. heterophyllum extracts 
 (NDK100328-4 &2) collected from different pools at Noordhoek in March  
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Figure 3.5 b 
1
H NMR (400 MHz, CDCl3) spectra of crude S. elegans extracts 
  (NDK100328-1 & 5) collected from different pools at Noordhoek in March 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 c 
1
H NMR (400 MHz, CDCl3) spectra of crude S. heterophyllum extracts 
 (NDK100727-4b) collected from different pools at Noordhoek in July 
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Figure 3.6 a 
1
H NMR (400 MHz, CDCl3) spectra of crude S. elegans extracts  
 (KOS100329-5) collected from different pools at Kenton on Sea in March 
 
These results allowed for the comparison of Sargassum metabolite profiles obtained from 
specimens collected at different sites within the same month. Results from this comparison 
showed that there was no qualitative variation of metabolites between different sites in the 
same season (figure 3.7). 
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Figure 3.7 
1
H NMR (400 MHz, CDCl3) spectra  of crude S. elegans extracts collected from 
 different sites in March (PA- Port Alfred, NDK- Noordhoek, KOS- Kenton on Sea) 
 
3.2.3.2 Seasonal Variation 
Seasonal variations of metabolites were evaluated by comparing metabolite profiles of algae 
collected at the same site within different months firstly within species then between species. 
This was done for S. heterophyllum collected from Port Alfred (PA) in July and September 
(figure 3.8) and for the same species collected from Noordhoek (NDK) in March and July. 
Similar comparisons were also made for S. elegans collected from Port Alfred in March and 
September. Again no significant differences were noted between all metabolite profiles other 
than the appearance of sargaquinoic acid (1.39) from the air oxidation of sargahydroquinoic 
acid (1.38). 
 
 
 
 
 
KOS 
NDK 
PA 
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Figure 3.8 
1
H NMR (400 MHz, CDCl3) spectra of crude S. heterophyllum extracts collected 
 from Noordhoek (NDK) in July and September 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 
1
H NMR (400 MHz, CDCl3) spectra of crude S. heterophyllum and S. elegans 
 extracts collected from Noordhoek in March 
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This preliminary investigation of the qualitative geographic and seasonal variation of 
secondary metabolites from S. heterophyllum and S. elegans showed that there is no variation 
amongst metabolites of both S .heterophyllum and S. elegans species collected at the sampled 
sites. This was the case with samples collected at two of the three sites namely; Noordhoek 
and Port Alfred (figure 3.9). Unfortunately no specimens of S. heterophyllum were found at 
Kenton on Sea when sampling was carried out at this site in March. Results from this study 
suggest that the two species under investigation are chemically in-distinct. The present study 
was successful in finding that the collection of S. heterophyllum from any three of the 
sampled sites in the sampled months will qualitatively yield the same metabolites. This was 
important for the future collection of algae for metabolites required for the rest of this 
research study. 
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3.3 Experimental 
3.3.1 General Experimental 
All solvents used were of analytical grade and were used without further purification from 
commercial sources. Organic extracts were dried under reduced pressure.
 1
H-NMR spectra 
were acquired on Bruker either a 400 MHz or 600 MHz spectrometer. Deuterated chloroform 
(CDCl3) was used for all 
1
H-NMR determinations. All experiments were carried out in 
duplicate.  
 
3.3.2 Plant Material 
Specimens of both Sargassum species were collected by hand on three different sites along 
the eastern coast of South Africa: Port Alfred (PA), Kenton on Sea (KOS) and Noordhoek 
(NDK). S. heterophyllum was collected from NDK and PA in March and July respectively 
while S. elegans was collected from all three sites in March and from PA in July. These sites 
were selected mainly due to their proximity to the laboratory as well as their ease of access. 
S. heterophyllum and S. elegans were differentiated based on morphological differences. 
Algae with conical holdfasts as well as triangular branches were classified as S. 
heterophyllum while specimens with circular holdfasts and branches in addition to branched 
receptacles were classed as specimens of S. elegans.  
 
3.3.3 Optimization of extraction solvents  
Several plants of S. elegans (PA100331) were washed with deionised water and blotted dry. 
The stipes were removed, placed in a pre-chilled mortar and crushed with liquid nitrogen. 
Approximately 2 mL of biomass was placed in a centrifuge tube and made up to 10 mL with 
one of the following solvents: EtOH, acetone and a mixture of CH2Cl2-MeOH (2:1) one 
centrifuge tube of crushed algae was left without solvent. Upon arrival at the laboratory (2 
hours later) samples were sonicated for 5 minutes and centrifuged at constant speed for 
another 5 minutes. 3 mL of the liquid extract was withdrawn and concentrated under reduced 
pressure. The crude extract was then analyzed by 
1
H NMR spectroscopy. 
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3.3.4 Intra-site and Inter-site differences and Geographical variation 
Frozen individual specimens were allowed to thaw at room temperature and subsequently 
extracted in duplicate as outlined above.  
 
3.3.5 
1
H-NMR analysis  
Concentrated crude extracts were dissolved in CDCl3 and 
1
H NMR data acquired on a Bruker 
400 MHz spectrometer. The same volume (500 µL) of CDCl3 was used for the analysis of 
each extract. 
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Chapter 4 
A Comparison of four different techniques for the extraction of metabolites 
from S. heterophyllum using qH NMR 
4.1 Introduction  
After determining the most suitable times and sites of collection for S. heterophyllum, gram 
quantities of sargahydroquinoic acid (1.38) were required to further explore the biological 
activity of this secondary metabolite. The extraction of compounds from plant matter is the 
first step towards the analysis of metabolites from natural products. It is thus regarded as a 
fundamental process in the study of natural products (Mandal V. et al., 2007). The 
preparation of plant material before extraction is equally important as it has the potential to 
affect the metabolites isolated from plant material. The main purpose of this part of the study 
was to optimize the extraction of sargahydroquinoic acid (1.38) from S. heterophyllum. The 
extraction of this and other metabolites using different extraction techniques was investigated 
and the extraction capacity of each method quantitatively assessed by NMR.  
 
4.1.1 Overview of commonly used extraction techniques 
Different methods have been employed in the extraction of natural products (Cravatto, 2008; 
Raynie, 2006). These techniques play a significant role in both analytical and natural 
products chemistry as they influence the recovery and stability of the extracted metabolites 
(Raynie, 2006). The careful selection and optimisation of extraction methods to suit their 
particular application is important to prevent chemical alteration of extracted metabolites   
(Cravatto, 2008). Some of the commonly used extraction methods include soxhlet, 
maceration, percolation, ultrasonic and microwave assisted extraction (Cravatto, 2008; Shen 
and Shao, 2005). Unfortunately, some of these methods of extraction are time consuming and 
expensive in that they require significant volumes of solvents (Shen and Shao, 2005). In 
addition to this, several solvents used in some extraction techniques are harmful to the 
environment and expensive to purchase and dispose of (Shen and Shao, 2005). These 
disadvantages have been the focus of the development of current and new extraction 
techniques (Raynie, 2006). 
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The most commonly used methods of solid-liquid extraction are based on the diffusion of 
metabolites from the plant matrix to the surrounding extraction solvent. It is for this reason 
that factors that affect diffusion such as temperature, duration of extraction, the size of plant 
material, solvent recycling and agitation have been explored in an effort to improve 
extraction yields (Mandal V. et al., 2007; Cravatto, 2008; Cravotto et al., 2004; Raynie, 
2006). A few of the commonly used solid-liquid extraction techniques are discussed below. 
 
4.1.1.1 Extraction by maceration  
Extraction of plant material by maceration has been documented to be the simplest and most 
economical method of extraction (Cravatto, 2008). Extraction by this method involves 
immersing plant material in extraction solvent and allowing metabolites to diffuse out of the 
plant material into the surrounding solvent (Mandal V. et al., 2007). Stirring during extraction 
has been shown to be important in preventing saturation of solvent closest to the plant 
material with extract. Such solvent saturation adversely affects extraction yields by impeding 
diffusion (Cravatto, 2008). Heating the solvent and plant material during extraction has 
proved to be useful; however, caution has to be exercised when selecting both the 
temperature and method of heating, especially where thermo-labile compounds are to be 
extracted (Cravatto, 2008). In addition to agitation and heating, the type and amount of 
solvent as well as the duration of extraction are key factors that affect extraction yields using 
this technique (Mandal V. et al., 2007; Cravatto, 2008; Cravotto et al., 2004; Raynie, 2006). 
 
4.1.1.2 Soxhlet extraction 
A Significant disadvantage of soxhlet extraction includes the lengthy extraction periods 
associated with this technique (Mandal V. et al., 2007; Cravatto, 2008).
 
Despite this 
disadvantage, this method makes use of important mechanisms such as solvent recycling and 
penetration into the solid matrix to facilitate high dissolution of metabolites from the plant 
material - often resulting in high extraction yields (Paik M.J. et al., 2004; Kim and Verpoorte, 
2009). It is for these reasons that extraction yields using this technique are dependent mainly 
on extraction times and solvent volumes in addition to other factors affecting diffusion as 
listed above.  
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4.1.1.3 Ultra Sound Assisted Extraction (USAE)   
Sonication of plant material during extraction facilitates the swelling and hydration of plant 
matrices resulting in the enlargement of cell wall pores (Cravatto, 2008; Kim and Verpoorte, 
2009). This disruption of cell wall structure increases the rate at which metabolites are 
transferred from the plant matrix into the surrounding solution (Cravatto, 2008; Kim and 
Verpoorte, 2009; Vinatoru M., 2001). In addition to the factors affecting diffusion, the 
extraction yields attained by this method are dependent on the type of solvent used in 
addition to the frequency at which extraction is carried out. Generally, the use of lower 
frequencies during extraction (18-40 KHz) results in higher extraction yields compared to 
compared to extraction under higher frequencies (400-800 KHz) (Cravatto, 2008).  
 
4.1.1.4 Microwave Assisted Extraction (MAE) 
Microwave extraction is based on the capacity of materials to absorb microwave energy and 
convert it to heat (Cravatto, 2008). Unlike conductive heating used in maceration and soxhlet 
extraction, microwave heating has its advantage in that it heats the entire sample 
simultaneously with little or no loss of heat to the environment (Cravatto, 2008). Microwave 
heating disrupts weak hydrogen bonds in the plant matrix by promoting the rotation of 
molecular dipoles and in so doing disrupts cell walls (Cravatto, 2008; Raynie, 2006). This 
effect, by which MAE functions, relies on both the characteristics of the solvent and the plant 
matrix from which compounds are to be extracted (Cravatto, 2008). In some cases, the 
microwaves disrupt weak hydrogen bonds in the plant matrix whilst the solvent remains cold. 
This is the case with solvents with low dielectric constants and  has  great advantages for the 
extraction of thermo-labile compounds (Cravatto, 2008). In addition to the microwave 
absorbing characteristics of the solvent, this method of extraction is also dependent on the 
power at which the extraction is carried out. A higher power invariably results in an increased 
temperature which may increase the extraction yield (Mandal V. et al., 2007). However, the 
power at which extractions are carried out should also be selected cautiously to avoid high 
temperatures, which could result in the degradation of thermo-labile metabolites. An 
interesting approach to improving both MAE and soxhlet extraction involves using the 
solvent recycling characteristics of soxhlet extraction while using microwaves as the source 
of heat (Priego-Capote and Luque de Castro, 2004). 
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Both ultrasound assisted and microwave assisted extraction have the potential to significantly 
reduce extraction times whilst positively influencing extraction yields. It is for this and other 
reasons that these two extraction techniques have been recognised as efficient methods of 
extraction (Cravatto, 2008; Cravotto et al., 2004).  
Once the method of extraction has been selected, there are several important factors that need 
to be considered for the optimal extraction of any target compound or group of compounds 
from natural sources (Kim and Verpoorte, 2009). These include the choice of solvent, ratio of 
solvent to biomass, duration of extraction as well as the temperature at which the extraction is 
to be carried out (Kim and Verpoorte, 2009). 
 
4.1.2 The selection of extraction solvents  
The choice of extraction technique may influence other extraction parameters such as the 
selection of extraction solvents (Kim and Verpoorte, 2009). For example, microwave heating 
of certain solvents may result in an abrupt increase in the internal temperature of a solution 
and this may lead to explosions which pose safety risks to researchers. On the other hand, 
certain solvents such as hexane cannot be heated by microwaves as they are transparent to 
them, while other solvents such as EtOH have good microwave absorbing capacities allowing 
for rapid heating of both the sample and the extraction solvent which may result in higher 
extraction yields (Mandal V. et al., 2007; Kim and Verpoorte, 2009; Letellier et al., 1999). 
The use of solvents such as hexane and chloroform is particularly useful for the extraction of 
thermo-labile compounds. Due to their transparency to microwave heating, these solvents 
allow for the selective heating of the plant matrix which facilitates the release of compounds 
from plant material with relatively less degradation of thermo-labile substances (Mandal V. et 
al., 2007). The physico-chemical characteristics of solvents such as polarity and selectivity 
for the analyte as well as the solvent’s potential toxicity to the user and its inertness towards 
metabolites being extracted are also important factors to be considered when selecting 
solvents for extraction (Kim and Verpoorte, 2009).  Solvent polarity is an essential factor in 
extraction as most metabolites are extracted by the ‘like-dissolves-like’ principle (Kim and 
Verpoorte, 2009). However, a variety of other factors may also enhance or retard extraction 
by this principle (Kim and Verpoorte, 2009). Where no published data with respect to 
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extraction solvents for certain metabolites exists, preliminary experiments are essential to 
determine the suitability of a solvent for extraction (Kim and Verpoorte, 2009). 
Table 4.1 Physical properties of extraction solvents used in the current study (Lide, 2003) 
Solvent Dielectric 
Constant (ε)  
Boiling Point 
(ºC) 
Dipole Moment 
 ( µ Debye units) 
Dichloromethane 9.08 40 1.60 
Methanol 33 65 1.70 
Ethanol 24.30 78 1.69 
Ethyl acetate 6.02 77 1.78 
Water 78.54 100 1.85 
Hexane 1.89 69 0.00 
 
Table 4.2 Solvents used to extract specific metabolites from Sargassum sp.  
Metabolite Solvent Reference 
Sargaquinoic acid MeOH (Kusumi et al., 1979; Perez-Castorena et al., 
2002; Seo et al., 2004) 
 CHCl3 (Tang et al., 2002) 
 EtOH (Segawa  and Shirahama, 1987) 
 MeOH-CH2Cl2 (Afolayan et al., 2008; Seo et al., 2006) 
 80% EtOH (Ham et al., 2010) 
 MeOH-CH2Cl2 (3:1) (Reddy and Urban, 2009) 
Sargahydroquinoic acid MeOH (Kusumi et al., 1979; Perez-Castorena et al., 
2002; Seo et al., 2004) 
 EtOH  (Segawa  and Shirahama, 1987) 
 MeOH-CH2Cl2 (Afolayan et al., 2008; Jung et al., 2008;  
Seo et al., 2006)  
 MeOH-CH2Cl2 (3:1)  (Reddy and Urban, 2009) 
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4.1.3 Other factors affecting extraction yields 
Regardless of the type of solvent used during extraction, only a certain amount of metabolites 
can be dissolved in a given amount of extraction solvent. It is for this reason that the ratio of 
solvent to plant biomass is also an important factor to be considered before extraction begins 
(Kim and Verpoorte, 2009). Generally, an increase in the amount of solvent results in an 
increase in the amount of analyte extracted due to the establishment of a steep diffusion 
gradient down which solutes may diffuse from the plant material into the surrounding solvent 
(Kim and Verpoorte, 2009). However, this may not be the case for techniques such as 
microwave assisted extraction in which high solvent volumes may result in low extraction 
yields due to insufficient stirring of extraction solvent by microwaves (Mandal V. et al., 
2007). This may be overcome by introducing mechanical agitation by using magnetic stirrers 
during extraction. The rate at which metabolites leave the plant matrix is also an important 
factor in attaining good extraction yields (Kim and Verpoorte, 2009). Where dissolution rates 
are low, the addition of energy into the extraction vessel e.g. by providing mechanical 
agitation, convectional currents or ultrasonication may increase extraction yields (Kim and 
Verpoorte, 2009). Dissolution is also impeded by metabolite–matrix interactions. In certain 
cases, the matrix may exhibit adsorbent properties which may result in low extraction yields 
despite adequate agitation (Kim and Verpoorte, 2009).  
As illustrated by the discussion above; many factors affect the optimisation of any given 
extraction technique. Such optimisation experiments require thorough investigations of these 
factors if they are to provide conclusive results. The techniques by which various extraction 
conditions and methods are quantitatively assessed are also of equal importance. 
 
4.2 Quantification of metabolites from natural sources.          
Several techniques for the quantitative analysis of metabolites from natural sources exist. 
These techniques such as HPLC and GC, IR, MS and NMR are important in the analysis of 
bioactive components from natural sources (Bilia et al., 2001). Each of these techniques has 
its own advantages and disadvantages; however, the ideal technique for the quantification of 
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metabolites from natural sources in metabolite profiling should be simple, efficient, suitable 
for the metabolites under investigation, adequately sensitive and reproducible.  
Quantitative NMR (qNMR) is a useful analytical technique as it has the potential to detect 
several metabolites in a relatively short time with little sample preparation. This technique 
has found widespread application in the identification and quantification of metabolites 
within complex biological samples (Viant, 2007; Harshey, 2003). 
 
4.3. NMR as a method of quantification  
NMR is one of the most widely used analytical methods in academic and industrial research 
(Malz and Jancke, 2005). Unlike many synthetic compounds, natural products are often 
formed in complex biological pathways occurring in the presence of many other compounds 
(Pauli et al., 2005). By allowing for simultaneous qualitative and quantitative analysis, NMR 
is valuable in the analysis of metabolites in their complex systems, as it removes the need for 
separation and other time consuming processes that are necessary for the use of other 
quantitative techniques (Pauli et al., 2005).
 
The development of NMR as a tool for 
quantification has been accelerated by the significant increase in sensitivity of this method of 
analysis due to the use of high-field NMR spectrometers and modern software packages that 
facilitate accurate and precise data processing (Pauli et al., 2005). In addition to this, the 
ability of this technique to quantitatively determine relative amounts of different compounds 
enables it to be used in the quantitative analysis of molecules in mixtures (Malz and Jancke, 
2005). This has important applications in natural products studies where crude extracts need 
to be screened in an effort to quantitate one or more metabolites. 
The advantages of qNMR as an analytical tool include its precision, reproducibility, non-
destructive nature and its ability to determine both qualitative and quantitative information on 
analytes (Pauli et al., 2005; Viant, 2007; Harshey, 2003; Verpoorte et al., 2007). The non-
destructive nature of this method is an added advantage in natural products laboratories 
where plant derived metabolites are valuable and scarce, making sacrificial analysis 
undesirable (Pauli et al., 2005). In addition to this, qNMR is a reliable technique which can 
be used in the analysis of NMR visible compounds such as ursolic acid which lack a 
chromophore or other physicochemical properties necessary for chromatographic detection 
(Pauli et al., 2005). 
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NMR has been used in the total identification and quantification of  metabolites in biological 
systems, a field known as metabolomics (Verpoorte  et al., 2007) Since many organisms 
produce the same primary metabolites, ideal metabolomic methods are those which are able 
to easily identify and quantify these metabolites with high reproducibility (Verpoorte et al., 
2007)  Despite the fact that many of the techniques used in metabolomics have their own 
advantages and disadvantages – the above mentioned advantages of  NMR make it suitable 
for use in metabolomic studies (Hagel and  Facchini 2008; Verpoorte et al., 2007) . The 
suitability of this method in metabolomics studies facilitates its use in the quantification of 
selected metabolites provided that certain criteria are met.  
 However, this technique is expensive due to the high cost of NMR spectrometers (Malz and 
Jancke, 2005). Another disadvantage of qNMR in comparison to other methods of 
quantitative analysis is its poor sensitivity (Wawer et al., 2008).  The limits of detection for 
1
H NMR on a high field spectrometer such as a 600 MHz spectrometer are around 10
-9
 while 
the same limits for IR and MS based techniques are about 10
-14
 and 10
-18
 respectively 
(Wawer et al., 2008). This disadvantage of qNMR stems from the fact that NMR sensitivity 
depends on the magnetic field strength, the nucleus under observation and the pulse sequence 
employed. These disadvantages may be reduced by increasing the number of scans during 
data acquisition, ensuring precise shimming as well as by improving sample concentration 
with the use of micro-coil technology (Wawer et al., 2008).  
 
4.3.1 Applications of qNMR 
QNMR has found applications in the quantification of compounds in mixtures, complex 
matrices and drug formulations and in the validation of reference compounds e.g. purity 
analyses, in biosynthetic, stability as well as reaction kinetic studies (Pauli et al., 2005; 
Diercks T. et al., 2001). This technique has the potential to play an important role in the 
regulatory analysis of pharmaceutical preparations of natural and synthetic drugs (Pauli et al., 
2005). The ability of qNMR to be used in stability and kinetic studies is of significance to the 
pharmaceutical industry, while its use in the quantification of one or more components from 
complex mixtures is of great importance to the study of natural products (Pauli et al., 2005). 
This technique’s potential to quantitate secondary metabolites has been utilised successfully 
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by various groups. A few examples of the use of qNMR in the quantification of compounds 
of natural origin are summarised in table 4.3 below.  
 
Table 4.3 Examples of natural product based studies in which qNMR was utilised as the 
 method of analysis (Pauli et al., 2005) 
Analyte(s) Natural Source Reference  
Cannabinoids 
 
Cannabis 
(Cannabis Sativa) 
(Choi et al., 2004) 
Capsaicin 
Gingerol 
Piperine 
Chilli 
(Capsicum spp) 
Ginger  
(Zingiber Officinalis) 
Black pepper 
 (Pipernigrum L.) 
(Catchpole O.J. et al., 2003) 
Bilobalide, 
Gingkolides A,B,C 
Ginkgo biloba leaves (Choi et al., 2003) 
 
4.3.2 Quantitative 
1
H NMR  
4.3.2.1 Principles of NMR quantification 
The key principles of qNMR reside in the fact that the area under an NMR signal, is directly 
proportional to the number of nuclei generating the signal (Rundlöfa et al., 2010; Pauli et al., 
2005). Hence, signal integration enables the determination of the ratio of components in a 
mixture (Pauli et al., 2005; Rundlöfa et al., 2010). Signal intensities (peak height) may also 
be used in a similar manner. However, the use of signal intensities as a measure of relative 
quantities is only valid when the NMR signal is represented by a single Lorentzian line, 
which rarely occurs (Pauli et al., 2005).
  
It is for this reason that integration of the area under 
the NMR signal is the most commonly used method of signal analysis in qNMR (Holzgrabe 
and Malet-Martino, 2011).  
The NMR active nuclei with highest natural abundance are 
1
H, 
19
F, 
31
P and 
15
N respectively. 
Due to the lower abundance of the other NMR susceptible nuclei such as 
13
C (1.1% relative 
abundance) compared to 
1
H (~100% abundance), the quantitative information obtained from 
these nuclei would be more difficult to obtain compared to that obtained from the more 
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abundant nuclei (Rundlöfa et al., 2010; Malz, 2008; Pauli et al., 2005). The use of other NMR 
susceptible nuclei such as 
19
F, 
15
N and 
31
P is limited to molecules containing these nuclei 
(Pauli et al., 2005). Of all the abundant NMR susceptible nuclei, only 
1
H is present in most 
organic molecules hence, 
1
H nuclei are the basis of most qNMR applications. Despite 
complex resonances of signals from several overlapping metabolite peaks in the 
1
H NMR 
spectra of mixtures, the development of NMR analysis software has enabled the de-
convolution of overlapping peaks to facilitate quantification from selected signals (Weljie et 
al., 2006; Dumas et al., 2002). In an effort to improve on the distribution of signals in the 
spectrum, 2D NMR experiments may be employed (Pauli et al., 2005). This is often the case 
with complex samples. However, these techniques e.g. COSY, HSQC and HMBC require 
longer acquisition times as well as more complex data processing compared to 
1
H NMR 
experiments (Pauli et al., 2005). 
 
4.3.3 Important aspects of qNMR analysis  
The two most important factors governing the successful use of qNMR include the 
appropriate selection of suitable quantitative conditions and post-acquisition processing 
parameters (Csaba, 1992). 
 
4.3.3.1 Quantitative experimental conditions 
The careful selection and optimisation of NMR parameters such as relaxation delay (D1) and 
acquisition time is essential for the accurate quantification of compounds by qNMR (Pauli et 
al., 2005; Pauli, 2001; Pinciroli et al., 2004).
 
The fundamental pulse scheme for obtaining 1D 
proton NMR data involves the following three primary parameters: relaxation delay, pulse 
width and acquisition time of the time domain data (Pauli et al., 2005). 
The relaxation delay (D1), represents the amount of time taken for excited protons to return 
to ground state after pulsing (Pauli et al., 2005; Holzgrabe et al., 1998). The relaxation delay 
is a property of the nucleus in a specific magnetic environment and is affected by the 
relaxation properties of other components in the mixture under investigation (Pauli et al., 
2005). Ideally, a sufficiently long D1 should be used to allow for equilibrium magnetization 
to be attained before the next pulse cycle begins (Pauli et al., 2005). It is often not feasible to 
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allow for the complete relaxation of all nuclei in a sample as long relaxation delays inevitably 
result in longer experimental times. It is thus common practice to determine the relaxation 
delay based on the relaxation properties of selected signals of target analytes when dealing 
with mixtures. The acquisition of NMR spectra under identical relaxation times should result 
in good quantification as each component of the mixture will be subject to identical 
relaxation phenomena
 
(Weljie et al., 2006). The acquisition time is usually selected on the 
basis of the spectral width in addition to the level of digital resolution required for that 
spectral width (Pauli et al., 2005). Usually, acquisition for 
1
H NMR spectra is selected such 
that spectral resolution is approximately 0.25 Hz or better
 
(Pauli et al., 2005). 
 
4.3.3.2 Post-acquisition data processing  
While the acquisition time is set prior to the NMR experiment, improvement of the digital 
resolution can be achieved by post acquisition data processing techniques such as zero-filling 
or linear prediction (Pauli et al., 2005). Once NMR spectra have been acquired, the use of 
appropriate processing techniques is essential. Phasing and baseline correction should be 
performed prior to integration as both these functions ensure that quantities represented by 
the various integrals will have minimal distortions, resulting in both accurate and 
reproducible quantification
 
(Pauli et al., 2005). These post acquisition processes can be 
applied either manually or automatically. Where manual processing is employed, integration 
will vary from operator to operator (Holzgrabe and Malet-Martino, 2011). 
Ideally, integration limits should be set to a range covering 64 times the width at half signal 
height as this ensures that 99% of the entire signal intensity is obtained (if the signal is a 
Lorentzian line) (Holzgrabe and Malet-Martino, 2011). This is a potential challenge firstly 
because NMR signals are not normally represented by Lorentzian lines and secondly because 
such a range may overlap with adjacent signals hence, a compromise has to be made 
(Holzgrabe and Malet-Martino, 2011). The accuracy of the integration procedure is also 
dependent on the signal to noise ratio (S/N) (Holzgrabe and Malet-Martino, 2011). 
Significant precision (standard deviation < 1%) has been attained for 
1
H NMR with minimal 
signal to noise ratios (S/N > 250:1) (Holzgrabe and Malet-Martino, 2011). 
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4.3.4 Reference compounds for quantification  
As for other methods of quantitative analysis, qNMR also requires the use of calibrated 
standards (Pauli et al., 2005; Holzgrabe et al., 1998; Henderson, 2002). Two main methods of 
calibration exist; these include external and internal calibration in which a pre-determined 
amount of an internal standard is added to the analyte or mixture for analysis (Pauli et al., 
2005; Holzgrabe et al., 1998; Henderson, 2002). External calibration is used when 
contamination of the analyte needs to be avoided. To achieve this, a special type of NMR 
tube with a coaxial capillary tube is used. The calibration standard is placed in the coaxial 
tube which is then inserted into the NMR tube containing the compound(s) to be analysed 
(Pauli et al., 2005; Holzgrabe et al., 1998; Henderson, 2002). Alternatively, two NMR tubes 
of analyte and standard are used and spectra of each determined separately (Pauli et al., 2005; 
Holzgrabe et al., 1998; Henderson, 2002). Recent technology has enabled quantification 
using electronically generated signals in the NMR spectrum (Silvestre V. et al., 2001). This 
can be achieved by making use of the ERETIC (electronic reference to access in vivo 
concentrations) or PULCON (pulse length based concentration determination) methods 
which remove the need for using a separate compound as an internal standard for 
quantification (Holzgrabe and Malet-Martino, 2011; Silvestre V. et al., 2001). However, 
where one is used, an ideal internal standard for qNMR should be readily available in high 
purity, inexpensive, stable, chemically inert and should not be volatile or hygroscopic to 
avoid changes during handling which may adversely affect quantification. In addition to this, 
a good standard for qNMR should have a short relaxation time and a relatively simple NMR 
spectrum with unique signals which are well removed from those of the target analyte(s) 
 
(Pauli et al., 2005; Rundlöfa et al., 2010). 
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4.3.5 Quantitative Analysis 
For the analysis and eventual quantification of compounds by qNMR, one of two approaches 
may be used (Pauli et al., 2005; Holzgrabe et al., 1998; Malz and Jancke, 2005).  
a. Relative Method  
This is essentially the determination of ratios of components in compound mixtures. The 
molar ratio nx/ny of two components X and Y may be calculated using the integrals of 
sufficiently separated signals as follows: 
  
   
  
  
  
  
 . 
  
  
      (1)          
 Where nx is the number of moles of analyte x, I is the integral of the selected NMR signal 
and Nx is the number of nuclei contributing to the integral of x. 
b. Absolute Method   
Two different absolute methods may be employed for the quantitative analysis of content or 
concentration. (Pauli et al., 2005; Holzgrabe and Malet-Martino, 2011; Malz and Jancke, 
2005)  
(i) The 100% method in which all compounds appearing in the spectrum are known and can 
be both unambiguously assigned structurally and quantitatively measured. 
(ii) Calculation of the main component Px with the use of a standard of known concentration 
Pstd as follows  : 
   
   
  
 
    
  
 
  
    
 
    
 
                      (2) 
        
Where: Mx and Mstd are the molecular weights of analyte (m) and standard (std), m and mstd 
are the weights of analyte and standard respectively, Nx and Nstd are the number of 
contributing nuclei of the relevant signal and Px and Pstd are the concentrations of standard 
and analyte respectively. 
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The main objective of the work presented in this chapter was to develop the most appropriate 
method for the extraction of sargahydroquinoic acid (1.38) from S. heterophyllum. The 
methods investigated in this study include maceration, soxhlet, ultrasound and microwave 
assisted extraction. The amount of sargahydroquinoic acid and other tetraprenylated 
metabolites extracted by each technique was quantified by qNMR.  
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4.4 Results and Discussion  
4.4.1 Effect of drying method on the metabolite profile of S. heterophyllum 
In chapter three it was shown that there is almost no intra-site variation of metabolites in 
freshly collected S. heterophyllum. Here we investigated the effect of different drying 
methods on the metabolite profiles of S. heterophyllum. A portion of S. heterophyllum 
collected from Noordhoek was size reduced while another portion was air-dried in a fume 
cupboard for two weeks. Of the size reduced algae, a portion was freeze dried for 24 h while 
the rest was also air dried for two weeks. The three batches of algae were extracted by 
ultrasound assisted extraction with DCM-MeOH (2:1) as the extraction solvent. Comparison 
of spectra obtained from this section of the study (figure 4.1) showed no qualitative 
differences between algae prepared by the three different methods. This was somewhat 
surprising since we have previously observed the relatively rapid conversion of 
sargahydroquinoic acid (1.38) to sargaquinoic acid (1.39) during purification. Freeze drying 
as the method of biomass preparation was selected for this study due to the shorter time 
period associated with freeze drying algae compared to air drying. 
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Figure 4.1 
1
H NMR spectra (400 MHz, CDCl3) of crude extracts obtained from  
 S. heterophyllum dried by different methods 
 
 
 
Size Reduced – Freeze Dried Algae 
Whole –Air Dried Algae 
Size Reduced –Air Dried Algae 
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4.4.2 Development of a quantitative NMR method for the analysis of crude extracts of 
  S. heterophyllum  
4.4.2.1 Selection of protons of interest 
The tetraprenylated toluquinones; sargahydroquinoic acid (1.38) and sargaquinoic acid (1.39) 
have relatively simple 
1
H NMR spectra (figure 4.2). However, in the presence of other S. 
heterophyllum metabolites most of these signals are obscured. Despite this, a doublet due to 
the methylene protons (H-1’) at δ 3.3 ppm in sargahydroquinoic acid and δ 3.1 ppm in 
sargaquinoic acid, are characteristic signals of these compounds which are visible even in the 
spectra of crude extracts. Sargachromenol (2.10), also a metabolite of S. heterophyllum  has 
relatively unobscured signals such as the doublet at δ 5.6 ppm (figure 4.2) due to an olefinic 
methine proton (H-2’).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 - Comparison of Extraction Techniques 
 
 
78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 
1
H NMR spectra (400 MHz, CDCl3) of sargahydroquinoic acid (1.38), 
 sargaquinoic acid (1.39) and sargachromenol (2.10) showing protons selected for 
 integration in qNMR  
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4.4.2.2 Selection of an internal standard for quantification 
The internal standard for quantification was selected from a literature search of internal 
standards used for the qNMR analysis of natural products. From this search, pyridine, N, N-
dimethylformamide, dichlorophthalonitrile and benzene where selected and investigated as 
potential internal standards for the current study. N,N-dimethylformamide (DMF) was 
selected as the internal standard because of its relatively simple 
1
H NMR spectrum which 
contains an aldehyde signal at δ 8.0 ppm. This and other signals in the 1H NMR spectrum of 
DMF are well removed from the selected signals of the target analytes (figure 4.3). The 
relatively high boiling point of DMF was an added advantage for its use as an internal 
standard as it meant that the internal standard was unlikely to evaporate during sample 
preparation, thus preventing inaccurate quantification. After the selection of the internal 
standard, the suitability of all selected signals for quantification was assessed. This was done 
by obtaining an HSQC spectrum of one of the crude extraction mixtures to be analysed 
(figure 4.4). This spectrum showed no overlap between the selected signals and other signals 
in the crude spectrum. 
 
Figure 4.3 
1
H NMR spectrum (600 MHz, CDCl3) of crude S. heterophyllum with internal 
 standard (DMF- N,N-dimethylformamide, SCHR- sargachromenol (2.10), SHQA- 
 sargahydroquinoic acid (1.38) and SQA- sargaquinoic acid (1.39) ) 
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Figure 4.4 HSQC spectrum (600 MHz, CDCl3) of crude S. heterophyllum with DMF 
 
4.4.2.3 Quantification of metabolites in S. heterophyllum  
Pre-weighed extracts were dissolved in 700 μL CDCl3 containing 0.1% v/v DMF as the 
internal standard. Each extract was sonicated for 30 seconds and filtered into a 5 mm 
diameter NMR tube. NMR spectra were acquired on a 600 MHz Bruker Avance 
spectrometer, using 32 scans and a relaxation delay of 10 seconds. Other studies using DMF 
as an internal standard for qNMR have used a D1 of 12.5 seconds (Catchpole O.J. et al., 
2003) however, the number of scans and D1 were selected to give reasonable experimental 
times. A D1 of 10 seconds was also selected based on T1 values of the signals of interest to 
this study (table 4.4). The selected D1 allowed for the total relaxation of the selected protons 
in all target compounds however, it did not allow for the total relaxation of the selected 
proton of the internal standard.  
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Table 4.4 T1 values of selected protons 
Compound Signal of interest           
(δH) 
T1                     
(seconds) 
N,N-dimethylformamide 7.99  5.67 
Sargahydroquinoic acid (1.38) 3.27  0.83 
Sargaquinoic acid (1.39) 3.12 0.97 
Sargachromenol (2.10) 5.57 1.81 
 
A macro (table 4.5) with preset parameters was developed to locate and integrate peaks of 
interest. This macro was developed based on the integration of target peaks from varying 
points. For the internal standard, integration of the signal of interest in a mixture of crude 
sample was performed from various points. It was shown that integration with or without 
spinning sidebands yielded a difference of less than 0.2 % between the integral with and the 
integral without side bands (table 4.6). The same process was carried out for all the other 
signals and limits yielding more than 98% of the signal area were selected. NMR analysis of 
DMF showed no impurities, hence, no allowance was made for impurities during the final 
quantification calculations.  
Table 4.5 Range of chemical shifts used in the integration of selected NMR signals 
 
  
  
 
 
Table 4.6 Integration limits used to select the most suitable integration limits for DMF 
Integration Range Integral 
8.19190  - 7.83291 (with spinning sidebands) 1.00000 
8.14953 - 7.87662 (without spinning sidebands) 0.98738 
8.09909 -7.94934 0.97911 
8.06937 -7.95906 0.97441 
 
Compound  Integration Range            (δH ppm) 
N,N dimethylformamide (DMF) 8.1495  7.8766 
Sargahydroquinoic acid (1.38) 3.34730 3.1971 
Sargaquinoic acid (1.39) 3.1480 3.1020 
Sargachromenol (2.10) 5.5982 5.5330 
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The signal-to-noise ratios of the selected signals ranged from 844:1-33:1 for the sample 
containing the least amount of sargahydroquinoic acid and from 895:1-122:1 for the extract 
containing the highest amount of sargahydroquinoic acid (table 4.7). The amounts of 
sargahydroquinoic acid (SHQA), sargaquinoic acid (SQA) and sargachromenol (SCHR) 
obtained by each extraction technique were calculated using the relative method as outlined 
in equation (1). The quantities of each metabolite extracted under various extraction 
conditions are listed in table 4.8. 
Table 4.7 Signal to noise ratios (S/Ns) calculated from peaks of each metabolite 
Analyte S/N  of sample containing 
 highest amount of SHQA (1.38) least amount of SHQA (1.38) 
N,N-dimethylformamide 895 844 
Sargahydroquinoic acid (1.38) 714 430 
Sargaquinoic acid (1.39) 122 33 
Sargachromenol (2.10) 144 42 
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4.4.3 Assessment of various extraction techniques 
4.4.3.1 Ultrasound Assisted Extraction 
Freeze-dried S. heterophyllum (1 g) was sonicated in solvent (10 mL) while the temperature 
was maintained at 25°C. The mixture was filtered and the solid material washed with an 
additional 10 mL of solvent. The crude extract was concentrated under reduced pressure and 
analysed by 
1
H NMR spectroscopy.  
 
Figure 4.5 Amount of sargahydroquinoic acid (SHQA), sargachromenol (SCHR) and 
 sargaquinoic acid (SQA) extracted using USAE 
Of the three solvent systems explored using USAE, DCM-MeOH yielded the highest mass of 
both crude extract and metabolites extracted per gram of biomass (figure 4.5). Not 
surprisingly, a steady increase in the mass of extracted metabolites was observed with an 
increase in extraction time or when the alga was extracted more than once. These results are 
in accordance with expected trends as longer extraction periods allow for higher amounts of 
metabolites to leave the plant matrix. Replacing extraction solvent steepens dissolution 
gradients between the plant material and the surrounding solvent. Interestingly, the masses of 
sargahydroquinoic acid extracted with two portions of DCM-MeOH for 10 minutes each (20 
minutes) and one portion DCM-MeOH for 30 minutes, were almost the same. The use of 
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three portions of solvent for 10 minutes yielded almost similar results to extracting for 30 
minutes with one portion of solvent. 
4.4.3.2 Microwave Assisted Extraction 
Freeze-dried alga (0.5 g) was placed in a glass 10 mL capped microwave vial and extracted in 
a microwave in 5 mL of solvent. The mixture was filtered and washed with an additional 5 
mL of solvent. The crude extract was concentrated under reduced pressure and analysed by 
1
H NMR spectroscopy. 
 
*Extraction performed with agitation 
Figure 4.6 Amount of sargahydroquinoic acid (SHQA), sargachromenol (SCHR) and 
 sargaquinoic acid (SQA) using MAE
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The effects of agitation, extraction time, microwave power and temperature were explored 
using microwave assisted extraction. The introduction of agitation while extracting with 
DCM-MeOH at 25°C and 50 W resulted in an increase in the amount of sargahydroquinoic 
acid extracted by 11.8 mg (figure 4.6). An increase in the extraction time at 50 W resulted in 
an increase in the quantities of all three metabolites extracted per gram of biomass. However, 
the use of agitation while extracting at 50 W and 25°C for 10 minutes resulted in the 
extraction of more sargahydroquinoic acid, compared to extracting at the same power and 
temperature for 30 minutes without agitation. It was also interesting to note that an increase 
in temperature from 25 to 40ºC yielded similar results to increased extraction time.  Hence, 
simply increasing the temperature from 25 to 40ºC has the potential to cut extraction time by 
20 minutes, at a power of 50 W with DCM-MeOH as the extraction solvent. An increase in 
the extraction power from 50 to 100 W also resulted in an increase in the amounts of all three 
metabolites extracted. The same trends were also observed for the extraction of all three 
metabolites using EtOH. The highest amount of sargahydroquinoic acid extracted using this 
technique was attained using EtOH by increasing both extraction temperatures and extraction 
power from 25°C to 40°C and 50 W to 150 W respectively. These conditions were not 
attempted with the DCM-MeOH for safety reasons. The highest amounts of sargaquinoic acid 
and sargachromenol were obtained from extraction with DCM-MeOH for 30 minutes at 25°C 
and 50 W. Although not many parameters were investigated with EtOH as the extraction 
solvent, the extraction of biomass with this solvent for 10 minutes at 150 W and 40°C yielded 
the highest amount of crude extract and sargahydroquinoic acid. It is clear that this method of 
extraction has good potential for efficient, fast, easy and environmental friendly extraction.  
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4.4.3.3 Maceration and Soxhlet Extractions 
Maceration Extraction 
Freeze-dried alga was placed into a 50 mL round bottomed flask fitted with a reflux 
condenser. The material was extracted in 10 mL of solvent for 30 minutes over a temperature 
controlled water bath. Extractions were carried out between 37.5 and 38ºC. The mixture was 
filtered and the solid material washed 10 mL of solvent. The crude extract was concentrated 
under reduced pressure and analysed by 
1
H NMR spectroscopy. 
Soxhlet Extraction 
A classical soxhlet apparatus was used in which 5 g of freeze-dried alga was extracted with 
200 mL of solvent for 5 hours. The mixture was filtered and the solid plant material was 
washed with 20 mL of solvent. The crude extract was concentrated under reduced pressure 
and analysed by 
1
H NMR spectroscopy. 
 
Figure 4.7 Amount of sargahydroquinoic acid (SHQA), sargachromenol (SCHR) and 
 sargaquinoic acid (SQA) extracted by maceration and soxhlet extraction 
A comparison of results from maceration and soxhlet extraction yielded interesting results in 
that DCM-MeOH gave the highest yield of sargahydroquinoic acid for extraction by 
maceration while EtOH gave the highest yield for soxhlet extraction (figure 4.7). Where the 
optimisation of extracted metabolites is concerned, extraction by soxhlet using the more 
environmentally benign EtOH as the extraction solvent yielded the highest amounts of all 
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three metabolites. However, in interpreting these results important factors need to be taken 
into account. It was expected that soxhlet extraction would yield more material firstly 
because the solvent: biomass ratio employed in this technique (1:40) was much larger than 
the same ratio in maceration extraction (1:10) and secondly soxhlet extraction was performed 
for 5 hours while maceration was only performed for 30 minutes. In addition to this, soxhlet 
extraction is generally expected to yield better extraction results compared to maceration as 
the former technique makes use of solvent recycling to increase analyte diffusion rates. A 
more rational comparison of the two techniques would entail using the same solvent: biomass 
ratios and extraction periods for both extraction techniques.   
Results from this study showed that the extraction of S. heterophyllum by soxhlet extraction 
using EtOH yields the highest amounts of sargahydroquinoic acid compared to the other 
extraction methods and conditions explored herein. The use of this solvent in microwave 
assisted extraction also shows great potential to yield high amounts of this metabolite. This 
could be due to the microwave absorbing characteristics of EtOH which are higher than those 
of all the other solvents used in this study.  
We have been able to optimise extraction techniques available to us for the extraction of 
sargahydroquinoic acid (1.38) from S. heterophyllum. In addition to this, the current study 
has enabled us to identify new extraction conditions that will facilitate environmentally 
friendly extraction while generating significantly higher amounts of target metabolites from 
S. heterophyllum. It would have been useful to compare results obtained from the qNMR 
study with those compared from gravimetric experiments; however, the rapid oxidation of 
pure sargahydroquinoic acid would have presented significant challenges for accurate 
gravimetric quantification of this metabolite.  Despite the relatively high standard deviations 
obtained in this study qNMR allowed for the simple and efficient quantification of analytes 
extracted by various techniques. 
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Table 4.8 Masses (mg /g of dry biomass) of crude extract, sargahydroquinoic acid (SHQA), sargachromenol (SCHR) and   
 sargaquinoic acid (SQA) extracted by each extraction technique 
 Ultrasound Assisted Extraction (USAE) 
 Average amount (mg/g) 
Solvent Time Crude 
extract 
SD SHQA SD SCHR SD SQA SD  
DCM:MeOH 5 min 16.08 0.76 7.42 1.53 1.87 0.02 0.93 0.69  
DCM:MeOH 10 min 18.32 4.33 7.04 1.69 1.94 0.01 0.75 0.21  
DCM:MeOH 15 min 21.16 3.79 10.33 2.90 2.53 0.02 0.99 0.33  
DCM:MeOH 30 min 28.56 1.31 17.09 8.04 3.92 0.05 1.39 0.53  
DCM:MeOH 60 min 36.22 2.04 20.27 1.22 4.73 0.00 2.33 0.62  
DCM:MeOH 10 min x 2 35.56 3.17 16.5 2.19 4.21 0.03 2.7 0.62  
DCM:MeOH* 10 min x 3 42.26 1.01 17.52 1.85 4.15 0.01 2.31 0.00  
EtOH 10 min 11.91 2.09 3.3 2.83 1.13 0.01 0.46 0.01  
EtOH* 10 min x 2 12.73 0.28 8.19 4.12 1.77 0.08 0.41 0.01  
EtOAc 10 min 21 2.19 5.43 0.63 1.11 0.04 1.37 0.01  
EtOAc 10 min x 2 17.3 5.11 6.35 3.44 2.38 0.05 1.28 0.01  
  Microwave Assisted Extraction (MAE) 
 
Solvent Time Power 
(W) 
Tempe-
rature 
Crude 
extract 
SD SHQA SD SCHR SD SQA SD 
DCM:MeOH 10 min* 50 25 37.38 5.30 13.02 25.78 5.28 0.06 3.65 0.03 
DCM:MeOH 10 min 50 ** 25 45.92 3.51 24.79 62.09 5.7 0.08 3.06 0.02 
DCM:MeOH 10 min 100 25 35.73 9.54 19.58 38.48 5.14 0.03 3.517 0.01 
DCM:MeOH 10 min 150 25 36.3 3.52 23.92 42.59 6.25 0.12 3.43 0.04 
DCM:MeOH 10 min 50 40 47.42 0.94 27 11.20 6.01 0.02 3.52 0.01 
DCM:MeOH  10 min x 3 50 25 47.17 20.13 23.6 79.56 8.13 0.20 6.28 0.08 
EtOH 10 min 50 25 21.84 0.67 4.56 10.39 2.37 0.01 1.75 0.01 
EtOH 10 min 50 40 26.74 6.16 7.74 25.65 3.21 0.02 1.91 0.01 
EtOH 10 min x 3 50 25 48.68 12.66 18.98 19.37 4.41 0.01 2.47 0.01 
EtOH 10 min 150 50 72.15 3.71 34.48 30.89 7.52  3.51 0.00 
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Soxhlet Extraction 
Solvent Crude 
Extract 
SD SHQA SD SCHR SD SQA SD    
DCM:MeOH 302.93 5.08 26.48 26.48 5.31 0.00 5.20 0.02    
EtOH* 537.3 18.96 61.61 75.6 31.7 0.7 22.7 0.25    
 Maceration 
Solvent Crude 
Extract 
SD SHQA SD SCHR SD SQA SD    
DCM:MeOH* 69.3 0.91 34.94 0.3 7.98 0.01 4.32 0.00    
EtOH* 59.6 3.43 20.97 0.3 5.06 0.01 3.59 0.03    
 
* Extractions in which n = 2 
**This extraction was performed with additional agitation 
SD = Standard deviation
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4.5 Experimental   
4.5.1 Solvents and reference compounds 
All solvents were of chromatographic grade (Merck, Germany) except for 95% ethanol which 
was redistilled before use. Deuterated Chloroform (99.8%), pyridine (99%) and N, N-
dimethylformamide (99.9%) were all supplied by Merck, Germany, while di-
chlorophthalonitrile (99 %) was obtained from Sigma- Aldrich, Germany. Sargahydroquinoic 
acid (1.38), sargaquinoic acid (1.39) and sargachromenol (2.10) were isolated from S. 
heterophyllum as outlined in chapter 2 (section 2.3.3). 
 
4.5.2 Plant material  
Specimens of S. heterophyllum (NDK101124 - 4) were collected from Noordhoek near Port 
Elizabeth, South Africa on the 24
th
 of November 2010. Algae was transported and stored as 
outlined in chapter 2, section 2.3.2.Some of the thawed algae was size reduced using liquid 
nitrogen in a mortar. Most of the crushed algae was freeze-dried on a Freezone ® 6 litre 
bench top freeze dryer system (Labconco, USA) for 24 hours while some of the size reduced 
algae together with the portion of whole algae was air dried in a fume hood for 14 days. The 
dry material was packed into air tight containers and stored at - 20°C until it was extracted.  
 
4.5.3 Extraction of plant material 
 4.5.3.1 Qualitative assessment of algae preparation prior to extraction 
Freeze dried, pre-sized reduced and whole air dried algae was extracted by ultrasound 
assisted sonication for 10 minutes as outlined below. 
1
H NMR spectra of the crude extracts 
were acquired on a Bruker Avance 400 MHz spectrometer and compared for qualitative 
differences. Extraction and analysis of metabolite profiles in this section of the study was 
performed in duplicate. 
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4.5.3.2 Quantitative investigation of extraction methods 
 All extractions were performed in triplicate except where indicated, using the same batch of 
freeze-dried material. Details of the extraction conditions for each extraction are summarised 
in table 4.8. 
Ultrasound assisted extraction (USAE)  
USAE was performed in a Soniclean® US 2/5 sonicating bath (Ultrasonic Manufacturing 
Company, South Africa). Freeze-dried material (1 g) was placed into a 15 mL polypropylene 
centrifuge tube with a screw cap. The solvent (10 mL) was added and the mixture sonicated 
while the temperature was maintained at 25°C. The mixture was filtered through a Hirsch 
funnel and washed with 10 mL of solvent.  
Microwave assisted extraction (MAE)  
Freeze-dried material (0.5 g) was placed in a 10 mL glass capped microwave vial and 
extracted in a CEM Matthews Model Discover (700W) microwave (CEM Corporation, USA) 
in 5 mL of solvent. The mixture was filtered through a Hirsch funnel and washed with 5 mL 
of solvent.  
Maceration (MAC)  
Freeze-dried material (1 g) was placed in a 50 mL round bottomed flask fitted with a reflux 
condenser. The material was extracted in 10 mL of solvent for 30 minutes over a Grant 
temperature controlled circulating water bath (Grant Instruments, UK). Extractions were 
carried out between 37.5 and 38ºC. The mixture was filtered through a Hirsch funnel and 
washed with 10 mL of solvent.  
Soxhlet Extraction (SOX)  
A classical Soxhlet apparatus was used in which 5 g of freeze-dried biomass was extracted 
with 200 mL of solvent for 5 hours. The mixture was filtered through a Hirsch funnel and 
washed with 20 mL of solvent.  
Evaporation of the filtered solvent extracts under vacuum (<40°C) using a Buchi rotovap  
(Buchi, Switzerland) gave the crude extract for each experiment. Crude extracts from each 
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extraction (4.1-21.6 mg) were weighed into vials which were stored at -4°C in a vacuum 
dessicator until they were analysed by NMR. 
 
4.5.4 NMR Analysis 
4.5.4.1 Sample Preparation 
A solution of 0.1% v/v DMF in CDCl3 was prepared by measuring 0.05 mL of DMF into a 50 
mL volumetric flask. The DMF was made up to 50 mL with CDCl3 and sonicated for five 
minutes. The contents of each vial were dissolved in 700 μL CDCl3 (containing 0.1% v/v 
dimethylformamide as an internal standard). Each sample was then sonicated for 30 seconds 
and filtered into a 5 mm diameter NMR tube.   
 
4.5.4.2 NMR apparatus and Parameters 
1
H NMR spectra of the crude extracts were acquired using a Bruker Avance 600 MHz 
spectrometer and referenced to residual CDCl3 solvent signal at δ 7.25 ppm. Automatic 
shimming was used on all samples. 
Table 4.9 Acquisition parameters for the NMR analysis of all samples  
NMR Parameter Value 
Temperature  300 K 
Pulse angle 30º 
Number of scans  32 
Pulse width 11.55 µs 
Pre acquisition delay  (DE) 6.00 µs 
Number of dummy scans  2 
FID Resolution 0.11 Hz 
Relaxation delay  10 seconds 
Spectral width  72.11KHz 
Acquisition time  4.54 seconds 
Number of FID points  65.54 KHz 
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4.5.3.3 Post acquisition processing 
MestreNova 6.0 (Mestrelab, Spain) was used for post acquisition processing. Before 
integration, each spectrum was automatically phase and baseline corrected.  
Signal integration 
A macro (table 4.5) with preset parameters was developed to locate and integrate peaks of 
interest. This macro was developed based on the integration of target peaks from varying 
points. For the internal standard, integration of the signal of interest in a mixture of crude 
sample was performed from various points. It was shown that integration with or without 
spinning sidebands yielded a difference of less than 0.2 % between the integral with side 
bands and the integral without (integrals one and two in table 4.6) The same process was 
carried out for all the other signals and limits yielding more than 98% of the signal area were 
selected. 
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Chapter 5 
 
Structure Activity Relationships of Antiplasmodial and Cytotoxic 
Sargahydroquinoic acid Derivatives 
 
 
5.1 Introduction  
 
The isolation of several grams of SHQA acid allowed the modification of specific functional 
groups in this compound in order to assess their effect on antiplasmodial and cytotoxic 
activity. The tetraprenylated toluquinones that have been isolated from S. heterophyllum are 
all made up of the same structural backbone. However, some of these metabolites possess 
greater activity than others (Afolayan et al., 2008). To the best of our knowledge, the 
mechanism by which sargahydroquinoic acid and other tetraprenylated toluquinones from S. 
heterophyllum exert their antiplasmodial activity is unknown. In addition to this, the 
pharmacophoric groups responsible for this compound’s biological activity are also 
unknown. The relative ease of acquiring these compounds from S. heterophyllum makes them 
good candidates for semi synthetic derivatisations. 
 
 
5.1.1 The development of ideal antiplasmodial agents 
 
Most antimalarial agents have not been developed from well-defined targets or mechanistic 
studies (Fidock et al., 2004; Laurent and Pietra, 2006). Some antimalarials such as quinine 
and to some extent artemisinin were identified from ethnopharmacology (Laurent and Pietra, 
2006; Fidock et al., 2004). The discovery of these compounds from nature led to the 
development of synthetic drugs such as chloroquine and artesunate whose activity was based 
on the structures of compounds from natural origin. Other drugs, such as tetracycline and the 
folate antagonists were identified from their treatment of other ailments (Laurent and Pietra, 
2006). With the increasing knowledge of the plasmodium parasite’s biochemistry and its 
recently characterised genome, several targets for the development of chemotherapeutic 
agents have been identified and utilised for drug development (Fidock et al., 2004; Laurent 
and Pietra, 2006; Gardner et al., 2002; Bahl et al., 2003). Some of these targets include 
enzymes such as protein kinases, DOXP reductoisomerase and protein farnesyl transferases. 
(Fidock et al., 2004) Before the successful culture of the asexual cycle of P. falciparum in 
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human erythrocytes in 1976, screening for antimalarial agents was accomplished by using in 
vivo avian and rodent models (Kayser et al., 2003). These models used different strains of the 
plasmodium parasites such as P. berghei, P. yoelii and P. chabaudi (Kayser et al., 2003).  
However, none of these parasites cause disease in humans. In addition to this, there are 
essential differences between the biology and pharmacokinetics in mice and in humans 
(Kayser et al., 2003). Despite these limitations, the development of drug resistant strains of 
these parasites has been useful in the identification of new compounds against human 
malaria. Hence, rodent malaria has played an important role in the development of human 
antimalarial agents (Kayser et al., 2003). Since the mechanism of action of chloroquine was 
discovered, haemoglobin has become a popular target for drug discovery. This has led to the 
development of several assays based on this target (Laurent and Pietra, 2006; Francis and 
Sullivan, 1997; Wright et al., 2001).  
 In vitro toxicity assays against several Plasmodium parasite strains also play a critical role in 
the discovery and development of antimalarial agents (Desjardins et al., 1979; Ziegler et al., 
2002). Pioneered by Desjardins in 1979, one of these assays is based on the parasite’s uptake 
of radioactive substrates such as hypoxanthine, palmitate or ethanolamine in the presence of 
the test drug (Fidock et al., 2004). These in vitro assays involve the culturing of P. falciparum 
in human erythrocytes in different concentrations of the compound under investigation. 
Media containing low levels of non-radioactive substrate is used for initial parasite culture, 
after which radioactively labelled substrate is added to cells followed by cell harvesting and 
measurement of the amounts of radioactive substance taken up by the parasites (Laurent and 
Pietra, 2006). IC50 values are then determined from analysis of dose dependent curves 
(Fidock et al., 2004). These assays enable high throughput screening as only 1 - 2 mg of the 
compound under investigation is required for screening (Laurent and Pietra, 2006).
 
The in 
vitro culture of the exoerythrocytic stages of P. falciparum in the liver using hepatocytes has 
also been accomplished (Kayser et al., 2003). However, these assays have not been used 
extensively in the evaluation of potential antimalarial agents (Kayser et al., 2003; Janse and 
Waters, 1995). Despite the disadvantages of relative high costs and complexity, the 
hypoxanthine assay has enabled the identification of both sensitivity and resistance of 
standard antimalarial agents to several P. falciparum strains (Kayser et al., 2003). Other 
simpler and cheaper assays such as colorimetric assays based on the detection of the 
reduction of nitro-blue tetrazolium to formazan by parasite enzymes have been developed. 
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However some of these assays are less sensitive than the hypoxanthine assay (Kayser et al., 
2003; Basco et al., 1995). 
The development of a good antiplasmodial agent not only depends on the agent’s toxicity 
towards the Plasmodium parasite but also on the agent’s toxicity to human cells (Mancini et 
al., 2009; Pink et al., 2005). An ideal antiplasmodial agent is one with higher antiplasmodial 
activity compared to cytotoxic activity. It has become common practice to compare 
antiplasmodial assay results to those obtained for the same compound in cytotoxicity assays 
(Laurent and Pietra, 2006).
 
Cell lines such as KB, P-388, HeLa, A-549, MEL-28, and A-549, 
which depend on similar rates of division of parasite and tumour cells, are used for this 
comparison (Laurent and Pietra, 2006). The values of these two assays are compared to each 
other by calculating a parameter known as the selectivity index. This index is a ratio of a 
compound’s cytotoxicity to its antiplasmodial activity (Laurent and Pietra, 2006). Ideally a 
compound’s cytotoxicity should allow for a selectivity index greater than ten (Mancini et al., 
2009).  
 
5.1.2 Quinone bearing compounds as antiplasmodial agents 
Several compounds which produce high levels of oxidative stress within the plasmodium 
infected erythrocyte have been identified (Lin et al., 1991;Vennerstrom and Eaton, 1988). 
These compounds include quinone bearing molecules such as quinones, hydroquinones, 
quinone methides and naphthoquinones in addition to other miscellaneous compounds such 
as thiosemicarbazone metal complexes and tetracyclines (Vennerstrom and Eaton, 1988; 
Figueiredo et al., 1998; Lin et al., 1991). Of these compounds, several naphthoquinones and 
quinones also have significant antiplasmodial activity  against P. falciparum  (Lin et al., 
1991). An example of one such agent is the compound  atavoquine, which is currently used as 
an antimalarial agent  (Olliaro, 2001). Two mechanisms by which naphthoquinones exhibit 
these effects have been proposed. These include the generation of reactive oxygen species 
through oxidation/reduction cycling and the inhibition of the enzyme dihydroorotate 
dehydrogenase which is involved in the synthesis of nucleotides (Olliaro, 2001). 
 
The main aim of this part of the project was to explore the antiplasmodial activity of a 
number of natural and synthetic analogues of sargahydroquinoic acid (1.38). Specifically, 
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attention was focused on the hydroquinone and carboxylic acid moieties of this compound 
(figure 5.1). The antiplasmodial and cytotoxic activity of these semi-synthetic derivatives was 
also evaluated. 
 
 
 
 
 
 
 
Figure 5.1 Proposed changes to the hydroquinone and carboxylic moiety of 
 sargahydroquinoic acid moieties in order to assess their effect on antiplasmodial and 
 cytotoxic activity (1.38)     
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5.2 Results and Discussion 
 
5.2.1 Chemical Modification of Sargahydroquinoic acid 
 
Sargahydroquinoic acid (1.38) is the major component of the DCM-MeOH extract of S. 
heterophyllum. Gram quantities of this natural product were isolated as described in section 
2.3.2.  
 
 
 
 
 
 
Sargahydroquinoic acid (1.38)     
 
Oxidation of sargahydroquinoic acid (1.38) to sargaquinoic acid (1.39) 
 
Although sargaquinoic acid (1.39) can be isolated from S. heterophyllum, the amount of 1.39 
that was isolated was very low. During the course of this work, we observed the oxidation of 
sargahydroquinoic acid (1.38) to sargaquinoic acid (1.39) in situ. However, this process 
occurred slowly hence, we sought to establish a procedure that would provide higher yields 
of 1.39. To this end, we explored a number of oxidation reactions in an attempt to optimise 
the formation of (1.39). There is ample precedence in the literature for the air oxidation of 
hydroquinones to quinones (Kusumi et al., 1979; Perez-Castorena et al., 2002) and this was 
the first reaction attempted. Vigorous stirring of a solution of 1.38 in acetonitrile provided 
inconsistent results and was not explored further.  However, both MnO2 and Ag2O converted 
sargahydroquinoic acid (1.38) to sargaquinoic acid (1.39) essentially in quantitative yields in 
less than 8 hours. Further optimization of the procedure by using two instead of one molar 
equivalents of Ag2O allowed for oxidation of 1.38 to 1.39 in significant yields, in less than 2 
hours. The structure of the semi-synthetic sargaquinoic acid (1.38) was confirmed to be 
identical to that of the naturally occurring compound by comparison of NMR data with that 
of sargaquinoic acid isolated in section 2.3.3. The use of other oxidising agents for the 
conversion of 1.38 to 1.39 was also briefly explored (table 5.1). 
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Table 5.1 List of oxidising agents investigated for the conversion of sargahydroquinoic acid 
 (1.38) to sargaquinoic acid (1.39)  
 
Oxidizing agent   Reaction Conditions  Isolated yield  
Air  ACN, rt, 12 h   30%  
Oxone  ACN,  rt,2 h  No Reaction  
Ag2CO3  CH2Cl2, (C6H15N), rt, 5 h  20%  
Ag2O  CHCl3,MeOH , rt, 2h /24h  70%   
MnO2  CHCl3, MeOH, rt, 24 h  95%  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 
1
H NMR spectra of sargahydroquinoic acid (1.38) and sargaquinoic acid (1.39) 
 (400 MHz, CDCl3)   
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The 
1
H NMR spectrum of the crude product obtained from the Ag2O catalysed oxidation of 
1.38 (figure 5.3) indicated the presence of small amounts of an impurity characterised by the 
presence of de-shielded resonances between  8.00, δ 7.98 and δ 7.51 ppm. Targeted isolation 
and purification of this “impurity” allowed for the identification of an unexpected side 
product (5.1). It was clear from the 
1
H NMR spectrum of 5.1 (figure 5.4) that there had been 
a change in the aromatic part of sargahydroquinoic acid with the appearance of two 
additional, mutually coupled aromatic doublets at  8.00 (J = 7.9) and δ 7.51 (J = 7.9).  In 
addition, one of the aromatic singlets had shifted downfield from  6.46 to  6.81 ppm    
 
Figure 5.3 
1
H NMR spectrum of the crude product obtained from the Ag2O catalysed 
 oxidation of sargaquinoic acid (400 MHz, CDCl3)
  
 
 
Figure 5.4 
1
H NMR spectrum of compound 5.1 (400 MHz, CDCl3)
 
with insert showing an 
expansion of the region between δ 8.1 and δ 7.4 ppm 
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Data from the 
13
C NMR spectrum of compound 5.1 revealed no changes in the number of 
carbon atoms in the starting material (1.38) and in 5.1. However, the 
13
C NMR spectrum 
showed the presence of two quinone carbonyls at (δ 184.44 and δ 184.41) and the carboxylic 
acid moiety ( 171.9).  In addition to this, the DEPT-135 NMR spectrum indicated the loss of 
one methyl signal ( 16.1, C-20’) and a methylene signal ( 121.7, C-2’) and the appearance 
of two additional olefinic methine signals (133.8 (C-2) and 125.9 (C-20)). 
 
Figure 5.5 Key HMBC correlations for compound 5.1 
 
HMBC correlations from the doublet at H 8.00 (H-1) to carbon signals at C 126.7 (C-1’) 
and C 133.8 (C-2’); H 7.51 (H-2) to the carbon signal at C 125.9 (C-20) and H 7.86 (H-20) 
to carbon signals at C 36.17 (C-4) and C 185.41 (C-4’) allowed for the assignment of a 
naphthoquinone moiety. Spectroscopic data for 5.1 were almost identical to a compound 
previously isolated from the Taiwanese soft coral, Nephthea chabrolii (Sheu et al., 2004).  
The only difference was the geometry of the C-10 double bond. The geometry of the C10/11 
double bond was assigned on the basis of comparison of proton chemical shifts of 5.1 to 
those of sargahydroquinoic acid (1.38), sargaquinoic acid (1.39) and 2’E, 6’E, 10’E - 
sargaquinal (1.40) and the known compound previously isolated from Nephthea chabrolii 
(Sheu et al., 2004). To this effect, the linear portion of 5.1 is consistent with Z geometry 
compared to compounds 1.38 and 1.39. For a Z geometry in the prenylated side chain the 
proton chemical shifts for H-10 and H-12 are approximately δ 5.96 and δ 2.26 ppm  
respectively while E geometry would show H-10 H-12 chemical shifts of 6.46 and δ 2.25 
ppm. 
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Table 5.2 NMR spectroscopic data for compound 5.1 (600 and 100 MHz, CDCl3) 
 
Carbon 
No   
δC δC , mult δH, mult, JHz  COSY HMBC 
1’ 185.44 C  -    
2’ 130.2 C  -    
3’   132.2 C       
4’ 185.41 C  -    
5' 136 CH 6.81, s H-7'   
6' 149 C  -    
7’ 16.44 CH3 2.18 s,  H-5' C-6',C-5' 
1 126.7 CH 8.00 d, 7.9  H-2 C-2',C-1' 
2 133.8 CH 7.51 dd, 7.9  H-4,H-20 C-1', C-20 
3 148.2 C -    
4 36.17 CH2 2.77, t, 7.6  H-5' C-5,C-3 
5 29.1 CH2 2.36 m  H-4,H-6 C-4,C-6,C-7 
6 123.2 CH 5.17 H-6   
7 136 C -    
8 39.01 CH2 2.08, m H-9 C-6, 
9 28.19 CH2 2.57, m H-10 C-8,C-10 
10 145 CH 5.96 t, 7.3 H-9 C-8 
11 130.6 C -    
12 27.77 CH2 2.26, m H-13, H-14lr C-13,C-14 
13 28.19 CH2 2.11, m H-14 C-15,C-11 
14 123.4 CH 5.17 ,t,7.0 H-13, H-14lr   
15  132.3 C     
16 25.63 CH3 1.68, s H-14lr C-15,C-14 
17 17.65 CH3 1.59, s H-14lr C-16 
18 171.9 C     
19 15.94 CH3 1.58, s H-6 C-6 
20 125.9 CH 7.86, s H-4 C-4',C-4 
 
 
The conversion of a prenylated hydroquinone such as 1.38 to a naphthoquinone is 
unprecedented and presents novel synthesis of these compounds. These compounds are 
usually synthesised by Diels-Alder type reactions between p-benzoquinones and dienes or by 
the prenylation of halogenated naphthoquinone moieties (Alonso et al., 2004; de Koning et 
al., 2003; Couladouros et al., 1996).  In view of the prominence of the naphthoquinone 
pharmacophore in antimalarial natural products the optimized chemical modification of 1.38 
to 5.1 was briefly investigated. The importance of time, temperature, catalyst and solvent 
were all explored.  At this point, a yield of 63% has been obtained by stirring the reaction 
vessel contents as outlined above for seven days. The following reaction scheme has been 
proposed for the conversion of 1.38 to 5.1. 
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Figure 5.6 Proposed scheme for the conversion of 1.38 to 5.1  
 
 
 
Methylation and acetylation of sargahydroquinoic acid (1.38) 
 
Methylation of alcohols may be achieved by Williamson ether syntheses using reagents 
bearing the required methyl group such as CH3I and (CH3O)2 SO2 (Sandulache et al., 2003; 
Smith et al., 1969). The semi-synthesis of the di-methyl ether of 1.38 was attempted by 
refluxing a mixture of sargahydroquinoic acid (1,38), (CH3O)2 SO2 , K2CO3  and acetone for 
16 hours followed by stirring at room temperature for a further 8 hours. This reaction yielded 
the hydroquinone methyl ester derivative of sargahydroquinoic acid (5.2). Upon standing this 
compound oxidised smoothly to give the corresponding quinone methyl ester (5.3). Our 
reaction conditions failed to attain the required selective methylation. This preferential 
esterification of the carboxylic acid moiety could have resulted from its stronger activity as a 
Lewis acid compared to the hydroxyl group on the hydroquinone moeity of 1.38. Further 
attempts to achieve selectivity were not investigated however, the use of other methylating 
agents such as CH3I or the use of protecting groups on this carboxylic group could still be 
explored in an effort to synthesise the di-methyl ether of 1.38. Key differences between the 
NMR spectra of the starting material and those of compounds 5.2 and 5.3 were the 
appearance of an extra methyl group at δ 51.0 ppm (5.2) and at δ 51.2 ppm (5.3). In addition 
to this, the carboxylic acid signal (C-18’) at δ 172 ppm in 1.38 was replaced by a signals at δ 
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168.4 ppm in both compounds 5.2 and 5.3. These signals are characteristic of ester carbonyls. 
The arrangement in the rest of the linear tetraprenyl chain remained intact for both esters.   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 
1
H NMR spectra of compounds 5.2 and 5.3 (400 MHz, CDCl3) 
 
 
Figure 5.8 
13
C NMR spectrum of compound 5.3 (100 MHz, CDCl3) with inserts showing 
expansions of regions between δ 169.0 and δ 168.0 ppm and δ 53 and δ48 ppm 
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Table 5.3 Comparison of 
1
H (400 MHz) and 
13
C (100 MHz) NMR spectroscopic 
 data for compounds 5.2 and 5.3 with 2D NMR data for the more stable 5.3 
Hydroquinone Methyl  Ester 
(5.2) 
Quinone Methyl  Ester 
(5.3) 
Carbon 
no. 
δC δH, mult, 
JHz  
δC δC mult δH, mult, 
JHz  
COSY HMBC 
1 146.37   187.92 C       
2 125.5   145.81 C       
3 115.42 6.50, s 133.1 CH 6.52,s     
4 148.88   187.87 C       
5 113.95 6.46, s 132.11 CH 6.44, s     
6 127.51   148.38 C       
7 17.64 1.76, s 16.07 CH3 1.65, s     
1’ 29.99 3.29, s, 
7.1 
27.48 CH2 3.11, d, 6.8 H-2', C-1, C-2', C-3' 
2’ 121.73 5.27, t, 
6.5 
117.97 CH 5.10, dd, 
7.5 
    
3’ 138.25   139.78 C       
4’ 39.5 2.07, m 39.56 CH2 2.05, d ,8.0   C-6', C-20' 
5’ 26.12 2.13, m 26.37 CH2 2.03, d, 8.0 H-6'   
6’ 124.2 5.09, m 124.39 CH 5.10, dd, 
7.5 
  C-8' 
7’ 134.78   134.6 C       
8’ 39.1 2.07, m 39.09 CH2 2.05, d, 8.0   C-7' 
9’ 28.05 2.56, dd, 
7.5 
27.95 CH2 2.49,dd, 
6.8 
H-10' C-8', C-10',C-
11' 
10’ 142.44 5.84, t, 
7.3 
142.06 CH 5.83, t,7.0  H-9' C-8', C-12', C-
18' 
11’ 131.32   131.36 C       
12’ 34.66 2.24, t, 
7.7 
34.66 CH2 2.22, t, 7.1 H-13' C-11',C-18' 
13’ 27.84 2.50, dd, 
7.5 
27.82 CH2 2.04,d H-14' C-15' 
14’ 123.45 5.09, m 123.46 CH 5.10, dd, 
7.5 
    
15’ 132.17   133.1 CH       
16’ 25.67 2.13, m 25.61 CH3 1.58, s     
17’ 16.17 1.59, s 17.59 CH3 1.55   C-16' 
18’ 168.59   168.42 C       
19’ 16.07 1.67, s 15.93 CH3 1.65, s     
20’ 15.99 1.76, s 15.84 CH3 1.61 , s     
21' 51.24 3.73, s 51.03 CH3 3.71, s   C-18' 
 
 
The of acetylation of the hydroxyl groups in the hydroquinone moeity of 1.38 was achieved 
by stirring a solution of sargahydroquinoic acid (1.38), acetic anhydride and pyridine at room 
temperature for 30 hours. This reaction resulted in the formation of compound 5.4. The 
1
H 
NMR spectrum of this compound was characterised by a shift in the aromatic signals from δ 
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6.50 ppm and δ 6.46 ppm in sargahydroquinoic acid to δ 5.21 ppm and δ 5.13 ppm for H-3 
and H-5 respectively in compound 5.4. This was due to the decreased effect of the oxygen’s 
electronegativity on carbons 3 and 5 as its electrons were now influenced by the more 
electronegative carbonyl oxygens attached to the newly added carbon atoms, C- 21’ and C-
23’. The 13C NMR spectrum of this compound showed the presence of four additional 
carbons at δ 169.6, δ 21.1, δ 169.0 and δ 20.5 ppm (C-21’, C-22’, C-23’ and C-24’ 
respectively) (figure 5.9). DEPT-135 NMR was used to confirm that two of these new 
carbons were quatenary carbons (C-21’ and C-23’) while the other two signals were 
confirmed to be due to methyl carbons (figure 5.10). The aromatic nature of the molecule was 
retained as was shown by the presence of the carbons at δ 145.2 and 148.0 ppm for C-1 and 
C-4 respectively.  
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Figure 5.9 
13
C NMR spectrum of compound 5.4 (100 MHz, CDCl3) with inserts showing 
expansions of regions between δ 171.0 and δ 168.0 ppm and δ 23 and δ 19 ppm 
 
 
 
Figure 5.10 DEPT 135 NMR spectrum of compound 5.4 (100 MHz, CDCl3) with the insert 
showing an expansion of the region between δ 23 and δ 19 ppm 
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Attempted conversion of (1.38) to sargachromenol (2.10) 
During the isolation studies, the slow conversion of sargahydroquinoic acid (1.38) to 
sargaquinoic acid (1.39) and finally to sargachromenol (2.10) was observed. The in vitro 
transformation of hydroquinones into quinones which are then converted to chromenols has 
been documented in literatutre (Kusumi et al., 1979; Perez-Castorena et al., 2002). It is also 
known that an equilibrium exists between hydroquinones, quinones and chromenols. 
Attempts to mimic the conversion of 1.38 to sargachromenol (2.10) by stirring solutions of 
1.38 in pyridine, and ethanol proved to be unsuccessful.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11 The proposed mechanism for the conversion of sargahydroquinoic acid (1.38) to 
 sargachromenol (2.10) 
 
 
Formation of sargaquinol (5.5) and sargachromendiol (5.6)  
 
Reduction of the carboxylic acid group in sargahydroquinoic acid was achieved under 
standard reducing conditions (LiAlH4) to afford two compounds; sargaquinol (5.5) and 
sargachromendiol (5.6). Two products were obtained from this reaction due to the presence 
of small amounts of sargachromenol in the sargahydroquinoic acid which was used as the 
starting material. We hypothesise that the carboxylic acid groups in both sargahydroquinoic 
acid and sargachromenol were reduced simultaneously. 
These alcohols were identified by the disappearance of the signal due to the carboxylic acid 
group at C 172 ppm and the appearance of an oxymethylene carbon signal at C 60.3 ppm in 
both compounds. These changes in the 
13
C NMR spectra were also accompanied by the 
emergence of new signals in the 
1
H NMR spectra at δ 4.1 ppm for both alcohols. In addition 
to the reduction of the carboxylic acid group in 1.38, this compound was also oxidised to the 
quinone. This was shown by the appearance of benzoquinone signals at δC 188.0 ppm and δ 
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187.8 ppm in 5.5 in place of the aromatic signals at δ 146.2 ppm and δ 148.6 ppm in 
compound 1.38 for C-1 and C-4 respectively. Apart from the changes at the carboxylic group, 
the rest of the tetraprenyl chain remained intact for both compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 
1
H-NMR spectra of sargaquinol (5.5) and sargachromendiol (5.6)  
 (400 MHz, CDCl3)
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Conversion of sargaquinol (5.5) to Z-sargaquinal (5.7) 
 
2’E, 6’ E, 10’E - sargaquinal (1.40) was initially isolated from S. heterophyllum in very small 
quantities (section 2.2.1). The aldehyde derivative of 1.38 was obtained by stirring a solution 
of sargaquinol (5.5) in anhydrous CH2Cl2 and Dess Martin’s Periodinane. The formation of 
an aldehyde was identified by the appearance of an aldehyde signal at δH 10.1 and δC 190.9 
ppm in the 
1
H and 
13
 C NMR spectra of 5.7 respectively. A comparison of 
1
H NMR spectra of 
the natural and derived aldehydes revealed differences in chemical shifts of both proton and 
carbon atoms associated with the aldehyde group. Spectra of the derived aldehyde (5.7) 
showed signals at δH 10.1 and δC 190.9 ppm compared to δH 9.55 and δC 205.4 ppm in the 
natural aldehyde (1.40). This prompted further investigation into compound 5.7 by 2D NMR. 
1
H-
1
H NOESY correlations in both compounds revealed a difference in the geometry of the 
C10’/11’ double bond with the derived aldehyde bearing a Z conformation at this bond. The 
derived aldehyde was thus identified as 2’E, 6’ E, 10’Z – sargaquinal, the geometrical isomer 
of the natural form of sargaquinal (1.40). The formation of 2’E, 6’ E, 10’Z - sargaquinal (5.7) 
from 2’E, 6’ E, 10’E - sargahydroquinoic acid has been reported in literature (Kusumi et al., 
1979). However,  no 
13
C or 2D NMR data for this compound has been previously reported for 
2’E, 6’ E, 10’Z – sargaquinal. 
 
 
 
 
 
 
 
 
 
 
2’E, 6’ E, 10’Z – sargaquinal (5.7) 
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Figure 5.13 
1
H-NMR spectra of the natural (1.40) and derived (5.7) sargaquinal  
 (400 MHz, CDCl3)
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Table 5.4 Comparison of NMR spectral data for the natural (1.40) and derived  aldehydes 
(5.7) (CDCl3) in addition to 2D NMR data for 5.7 
 
 Natural aldehyde 
(1.40) 
 Derived aldehyde 
 (5.7) 
Carbon 
No   
δC δH, mult, 
JHz 
δC δC, mult  δH, mult, 
JHz 
HMBC COSY NOESY 
1 187.96   187.96 C         
2 145.9   145.9 C         
3 132.3 6.54, s 132.27 CH 6.54, s C-1'     
4 187.91   187.91 C         
5 132.1 6.43, m 132.12 CH 6.43,m       
6 148.4   148.4 C         
7 16.0 2.06, m 15.99 CH3 2.05, d, 
6.3 
    H-5 
1’ 27.3 3.12, d, 
7.2 
27.33 CH2 3.13, d, 
6.9  
C-2', C-3' H-2' H-2' 
2’ 118.2 5.10, dt, 
6.8 
118.2 CH 5.14, d, 
5.8 
  H-1' H-4' 
3’ 139.9   139.9 C         
4’ 39.5 2.06, m  39.5 CH2 2.05, d, 
6.3 
      
5’ 26.4 2.06, m 26.4 CH2 2.14, dd, 
15.0, 6.8 
    H-6' 
6’ 125.5 5.10, dt, 
6.8 
125.5 CH 5.06, s   H-5'   
7’ 133.6   133.6 C         
8’ 39.4 2.24, m 39.38 CH2 2.05, d, 
6.3 
C-6' H-6' H-10' 
9’ 27.5 2.06, m 27.54 CH2 2.14, dd, 
15.0, 6.8 
  H-10' H-10' 
10’ 154.9 6.41, m 145.9 CH 6.43 m C-8', C-9'     
11’ 132.1   132.1 C         
12’ 27.3 2.24, m 27.33 CH2 2.64, m   H-13' H-10' 
13’ 25.7 1.67, s 27.45 CH2 2.14, dd, 
15.0, 6.8 
  H-12'   
14’ 123.6 5.10, t, 
6.8 
123.6 CH 5.14,d 
,5.8 
  H-13'   
15’ 133.2   133.2 CH         
16’ 25.2 1.67, s 25.15 CH3 1.67,s       
17’ 17.7 1.57, s 17.72 CH3 1.57, s       
18’ 205.4 9.55, s  190.9 C 10.08, s   H-10' H-12' 
19’ 16.0 1.62, s 16.04 CH3 1.62      
20’ 16.1 1.62, s 16.1 CH3 1.62       
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Conversion of sargahydroquinoic acid (1.38) to sargalactone (5.8)  
 
Several macrocyclic lactones have been shown to exhibit potent antiplasmodial activities. 
These include the bromophycolides recently discovered by the Kubanek group from the 
seaweed, Callophycus serratus (Stout et al., 2011). This was the motivation behind the 
attempted cyclization of sargahydroquinoic acid to sargalactone (5.8).  The conversion of 
1.38 to a lactone was achieved by stirring a solution of sargahydroquinoic acid, acetone, 
cyanuric chloride (C3Cl3N3) and triethylamine (C6H15N) at 30°C for 5 hours to give 
compound 5.8. The key differences between 
1
H NMR data for this compound and that of the 
starting material were an increased de-shielding of the aromatic protons from δ 6.5 ppm (H-3) 
and δ 6.47 ppm (H-5) to δ 6.96 ppm and δ 6.81 ppm for H-3 and H-5 respectively in 5.8 
(figure 5.14). This was expected in the intended product as the movement of the carbonyl 
oxygen to the aromatic region would contribute to an increased de-shielding of protons in this 
region. The 
13
C NMR spectrum of 5.8 also showed a key change in the chemical shift of the 
C-18’ signal from δ 172.4 ppm in 5.8 to δ 168.4 ppm in sargalactone (5.8), which is 
characteristic of a change from a carboxylic acid to an ester.  This information was supported 
by the mass spectral data of compound 5.8 which showed the expected molecular ion at m/z 
407.26 [M-H]
 +
. All 2D data supported the basic structure of this compound but no 
unambiguous correlations were observed connecting the carboxylic ester carbonyl and the 
aromatic ring system.  This is not unexpected due the long range correlations (5-bond) which 
are required.  Ultimately, an X-ray structure of this novel compound is required in order to 
unambiguously assign its structure, however, this reaction yielded insufficient material for x-
ray structure determination. 
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Figure 5.14 
1
H NMR spectrum of compound 5.8 (600 MHz, CDCl3)
 
with the insert showing 
an expansion f the region between δ 7.1 and δ 6.6 ppm 
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Table 5.5 NMR spectroscopic data for compound 5.8 (CDCl3) 
 
Carbon 
no. 
 δC δC, 
mult  
δH, mult JHz COSY  HMBC NOESY 
1  143.6 C         
2  123.6 C         
3  121.4 CH 6.96, s   C-1 H-5 
4  148.9 C         
5  118.8 CH 6.81, s       
6  127.1 C         
7  16.7 CH3 2.27, s   C-1   
1’  27.3 CH2 3.29, d, 37.5 H-2' C-2, C-2' H-20' lr 
2’  121.5 CH 5.33, dd, 
17.8, 10.1 
H-1' C-4' H-4', 
3’  132 C         
4’  39.4 CH2 2.12, m   C-3', C-5' H-6' 
5’  26.7 CH2 1.70,s H-6' C-3',    
6’  123.6 CH 5.17, d, 37.5    H-19' 
7’  135.3 C         
8’  39.1 CH2 2.12, m     H-6' 
9’  29.0 CH2 2.27, s       
10’  136.1 CH 5.87, t, 8.3   C-12' H-8', H9’ 
11’  133.5 C         
12’  34.5 CH2 2.36, t, 7.1 H-13' C-11', C-14' 
13’  27.4 CH2 2.12, m H-12'     
14’  123.3 CH 5.33, dd, 
17.8, 10.1 
      
15’  132.5 CH         
16’  25.7 CH3 2.27, s     H-14' 
17’  17.7 CH3 1.65, s   C-15, C-16' H-16' 
18’  168.4 C         
19’  14.4 CH3 1.57, d, 13.4   C-8' H-9' 
20’  16.1 CH3 2.27, s       
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5.2.2 Bioactivity of sargahydroquinoic derivatives and naturally occurring prenylated 
toluquinones  
 
The nine derivatives of sargahydroquinoic acid (1.38) together with the naturally occurring 
compounds; 2’E, 6’E-10’E -sargaquinal (1.40), sargachromenol (2.10) and sargahydroquinoic 
acid itself, were assessed for both antiplasmodial and cytotoxic activity. The 12 compounds 
were tested against the chloroquine resistant strain of P. falciparum, FCR-3 for 
antiplasmodial activity and against the MDA-MB-231 breast carcinoma cell line for cytotoxic 
activity.  
 
 
Antiplasmodial assay 
All compounds were tested in triplicate against the chloroquine-resistant Gambian FCR-3 
strain of P. falciparum.  
 
Cytotoxicity assay 
The cytotoxicity of the compounds was determined using the WST-1 assay method (Roche). 
Compounds were tested against MDA-MB-231 breast carcinoma cells. 
The selectivity index of these compounds was calculated by dividing the IC50 value (µM) 
obtained from the cytotoxicity assay with the same parameter obtained from the 
antiplasmodial assay. The results for both assays as well as the selectivity indices of all 
compounds are shown in table 5.6. 
 
 From the results, it was difficult to definitively discuss the structure activity relationships of 
the tested compounds. However, the following was observed: of the assayed compounds, four 
compounds were more active against the antiplasmodial parasite compared to 
sargahydroquinoic acid (1.38). These included sarganaphthoquinone (5.1), both the 
hydroquinone and quinone methyl esters (5.2 and 5.3) and sargalactone (5.8). These 
compounds also had good selectivity (> 10) for the plasmodium parasite except for the 
quinone methyl ester which had a selectivity index of 8.55. Most compounds had higher 
cytotoxic activity compared to the weakly cytotoxic sargahydroquinoic acid (1.38). The 
hydroquinone methyl ester (5.2) had the highest cytotoxic activity (44 µM). 
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Table 5.6 Bioassay results for compounds 1.38 – 1.40 and 5.1 – 5.8 
Compound Antiplasmodial 
activity(FCR-3) 
IC50 µM 
Cytotoxicity 
(MDA-MB-231) 
IC50 µM 
Selectivity Index 
(SI) 
Sargahydroquinoic acid (1.38) 38.58 70 1.81 
Sargaquinoic acid (1.39) 10.81 658 60.87 
Sarganaphthoquinone  (5.1) 5.44 2410 443.01 
Hydroquinone Methyl ester (5.2) 1.94 44 22.68 
Quinone Methyl ester (5.3) 8.19 70 8.55 
Hydroquinone di-acetate (5.4) 84.3 286 3.39 
Sargachromenol (2.10) 114.82 56 0.49 
Sargaquinol (5.5) 93.12 99 1.06 
Sargachromendiol  (5.6) 34.21 187 5.47 
Natural Sargaquinal (1.40) 104.43 69 0.66 
Derived Sargaquinal (5.7) 72.58 211 2.91 
Sargalactone (5.8) 5.22 107.9 20.67 
Quinine 0.17 - - 
 
In order to discuss the effects of functional groups on antiplasmodial activity, the tested 
compounds were separated into different groups based on the functional group at C-18’ in 
sargahydroquinoic acid or the moiety group at the head of the compound i.e quinone, 
hydroquinone or chromenol (table 5.7)..............................................................................
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Table 5.7 Antiplasmodial activity of compounds 1.38 -1.40 and 5.1 -5.8 
Common Moiety        Compound and IC50 value 
 
COOH 
 
 
 
  
 
 
 
 5.44 10.81 38.58 84.3 114.82 
 
 
 
 
COOMe (5.3) 
 
 
 
COOH (1.39) 
 
 
 
CHO (5.7) 
(Derived) 
 
 
 
CH2OH (5.5) 
 
 
 
CHO (1.40) 
(Natural) 
 8.19 10.81 72.58 93.12 104.43 
 
 
 
 
COOMe (5.2) 
 
 
 
COOH (1.38) 
   
 1.94 38.58    
 
 
 
 
 
CH2OH (5.6) 
 
 
COOH (2.10) 
   
 34.21 114.82    
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For molecules with a carboxylic acid functional group at C-18’, the naphthoquinone (5.1) had 
the highest antiplasmodial activity followed by the quinone bearing molecule, sargaquinoic 
acid (1.39). Amongst the molecules bearing a quinone moeity, the quinone methyl ester (5.3) 
was the most active. An interesting difference between the activity of the synthetic and 
natural aldehydes was also observed amongst molecules in this group. While both aldehydes 
did not show significant antiplasmodial activity, a change in the geometry at the C10’/11’ 
double bond seemed to affect both antiplasmodial and cytotoxic activity. This was seen by 
the higher antiplasmodial activity of the derived aldehyde (5.7) compared to its natural 
isomer (1.40) which is more cytotoxic than compound (5.7). The conformation at this bond 
may be further investigated where the cytotoxicity of these compounds is concerned. Another 
interesting difference in antiplasmodial activity is observed with the hydroquinone and 
quinone methyl esters with the former being the most active of all 12 compounds. Results for 
this compound (5.2) and the lactone (5.8) suggest that the hydroquinone moeity is important 
for antiplasmodial activity. If this is the case, increasing the lipophilicity of this compound 
further e.g. by methylating the hydroquinone hydroxyl groups of (5.2) or by increasing the 
ester’s chain length at C-18’ may provide more information on how the antiplasmodial 
activity of (5.2) may be improved. Sargalactone (5.8) was expected to show more cytotoxic 
activity based on deductions from other large macroesters such as geldanamycin. However, 
this compound’s antiplasmodial activity is in line with trends observed with the esterification 
of the carboxylic acid. Despite the fact that none of the derivatives had significant 
antiplasmodial activity, this study was successful in providing preliminary information on the 
functional groups that influence the antiplasmodial activity of sargahydroquinoic acid. 
 
 
 
 
 
 
 
 
Chapter 5 – SARs of Sargahydroquinoic acid derivatives 
 
 
125 
 
5.3 Experimental 
 
5.3.1 General Experimental  
 
All solvents were of chromatographic grade (Merck, Germany) and were used without further 
purification. Ethanol (95%) was redistilled before use. Column chromatography was 
performed with silica gel (40-63 μm particle size) from Merck, Germany. Normal Phase 
HPLC was carried out on a Phenomenex Luna C18 column (10mm × 250 mm, 10 μm), while 
a Whatman Partisil 10 semi-preparative column (10 mm × 500 mm, 10 μm) was used for 
reverse phase HPLC. NMR spectra were recorded on Bruker Avance 400 MHz and 600 MHz 
spectrometers and referenced to CDCl3 solvent signals δH 7.26 ppm and δC 77.0 ppm. UV 
spectra were obtained from a Perkin Elmer Lambda 25 uv/vis spectrometer while FT-IR data 
was measured using a Perkin Elmer Spectrum 100 FT-IR Spectrometer. High resolution mass 
spectroscopy (ESI) was determined on a Waters Synapt G2 mass spectrometer at 20 V. 
 
 5.3.2 Plant material 
Specimens of S. heterophyllum were collected from Noordhoek on the south east coast of 
South Africa. Algae was transported and stored as outlined in chapter 2, section 2.3.2. 
 
 
5.3.3 Extraction and isolation of sargahydroquinoic acid (1.38) 
The extraction and isolation of sargahydroquinoic acid (1.38) was carried out as outlined in 
section 2.3.3. 
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5.3.4 The Chemical Modification of Sargahydroquinoic acid (1.38) 
 
 
5.3.4.1 Oxidation of sargahydroquinoic acid (1.38) to sargaquinoic acid (1.39)  
 
 
 
 
 
 
 
 
 
 
Procedure A 
To a solution of 1.38 (154.0 mg, 0.36 mmol) dissolved in a mixture of CHCl3 (8 mL) and 
MeOH (7 mL) was added Ag2O (100 mg, 0.43 mmol). The reaction mixture was stirred at 
room temperature for 24 hours after which the resulting suspension was filtered through 
diatomaceous earth and concentrated under reduced pressure. The crude product was passed 
over a plug of charcoal in a solvent system of Hexane: EtOAc (40:60) to give a yellow 
mixture of compounds which was separated by silica gel chromatography Hexane: EtOAc 
(70:30). Separation of this crude mixture gave two yellow oils; sargaquinoic acid (1.38) (80 
mg, 70%) and compound 5.1 (9.8 mg, 6%). 
Sargaquinoic acid (1.39): 
1
H and 
13
C NMR data - see table 2.1.  
Sarganaphtoquinone (5.1): 
1
H and 
13
C NMR data see table 5.2  
UV (EtOH) λmax 205 nm; IR νmax (film) 1049, 1377, 1454, 1600, 1663, 2850, 2924 cm
-1
; 
EIMS m/z 419.22 [M-H]
 +
 
 
Procedure B 
To a solution of sargahydroquinoic acid (1.38) (94.1 mg, 0.22 mmol) dissolved in a mixture 
of CHCl3 (7 mL) and MeOH (8 mL) was added MnO2 (30.3 mg, 0.348 mmol). The reaction 
mixture was stirred for 24 hours at room temperature. The reaction mixture was then filtered 
through diatomaceous earth and concentrated under reduced pressure. The 
1
H NMR spectrum 
of the crude product showed 100% conversion of 1.38 to sargaquinoic acid (1.39). 
 
 
 
O
O
OHO
 
COOHO
O
1.38 
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Procedure C 
A solution of sargahydroquinoic acid (1.38) (25.1 mg, 0.06 mmol) dissolved in 5 mL of ACN 
was stirred for 14 hours at room temperature in an open round bottomed flask. The reaction 
mixture was concentrated under reduced pressure. The 
1
H NMR spectrum of the crude 
product showed 25% conversion of 1.38 to 1.39. 
 
Procedure D 
To a solution of sargahydroquinoic acid (1.38) (26 mg, 0.06mmol) dissolved in 5 mL ACN 
was added oxone (228.9 mg, 0.40 mmol). The reaction mixture was stirred at room 
temperature for 2 hours. The reaction mixture was filtered and concentrated under reduced 
pressure. The 
1
H NMR spectrum of the crude product showed that most of the starting 
material had not been converted to sargaquinoic acid. To a solution of the crude product 
dissolved in 5 mL ACN was added another portion of oxone (228.9 mg, 0.40 mmol). The 
reaction mixture was stirred at room temperature for 4 hours, filtered and concentrated under 
reduced pressure. The 
1
H NMR of the second crude product showed 20% conversion of 1.38 
to 1.39.  
 
Procedure E 
To a solution of sargahydroquinoic acid (1.38) (6 mg, 0.01 mmol) dissolved in 3 mL CH2Cl2, 
triethylamine (0.3 mL, 2.15 mmol) and Ag2CO3 (80 mg, 0.29 mmol) was added. The reaction 
mixture was stirred at room temperature for 5 hours, filtered and concentrated in vacuo. The 
1
H NMR spectrum of the crude product showed no conversion of 1.38 to 1.39. 
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5.3.4.2 Methylation of sargahydroquinoic acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To a solution of 1.38 (122.4 mg, 0.29 mmol) dissolved in 2 mL acetone, K2CO3 (207.4 mg, 
1.50 mmol) in 5mL acetone and dimethylsulphate (250 µl, 2.63 mmol) was added. The 
mixture was heated at 40°C for 8 hours followed by stirring at room temperature for 16 
hours. The reaction mixture was filtered and concentrated under reduced pressure. The crude 
reaction mixture was separated by silica gel column chromatography (Hexane: EtOAc, 80:20) 
to give compound 5.2 (50 mg, 44%). Upon standing the hydroquinone methyl ester (5.2) 
oxidised to the quinone methyl ester (5.3). The mixture of the two esters was separated by 
HPLC (Hexane: EtOAc, 80:20) to give two yellow oils; 5.2 (10 mg) and 5.3 (20 mg). 
Hydroquinone methyl ester (5.2): 
1
H and 
13
C NMR data- see table 5.3 
Quinone methyl ester (5.3): 
1
H and 
13
C NMR data- see table 5.3 
 
 
 
 
 
 
 
 
 
O
O
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OH
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5.3.4.3 Acetylation of sargahydroquinoic acid 
 
 
 
 
 
 
 
 
To sargahydroquinoic acid (1.38) (110.0 mg, 0.26 mmol), acetic anhydride (3 mL, 31.8 
mmol) and pyridine (2 mL, 24.8 mmol) was added. The reaction mixture was stirred at room 
temperature for 30 hours. The crude product was acidified with 1 M HCl (10 mL) and 
extracted with EtOAc (5 mL x 3). The organic layer was collected and concentrated under 
reduced pressure to give a crude product. The crude product was passed over a plug of 
charcoal in a solution of EtOAc: Hexane (60:40), concentrated under reduced pressure and 
purified by silica gel column chromatography (Hexane: EtOAc, 70:30) to give compound 5.4 
(12.8 mg, 12 %) as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ  6.81 (d, J = 7.5 Hz) (H-3), 6.76 (d, J = 2.4 Hz) (H-5), 5.21 (t, 
J = 6.5 Hz) (H-2’), 5.13 (d, J = 7.1 Hz) (H-6’, 14’), 3.18 (d, J = 7.0 Hz) (H-1’), 2.34 – 2.28 
(m) (H-23’, 24’)), 2.27 (d, J = 3.7 Hz) (H-12’), 2.17 (s) (H-7), 2.11 (d, J = 14.4 Hz) (H-5’, 
13’), 2.05 (s) (H-4’,8’,22’, 24’), 1.66 (d, J = 6.0 Hz) (H-16’, 19’,20’), 1.60 (d, J = 7.5 Hz) (H-
17’). 
13
C NMR (100 MHz, CDCl3) δ 171.5 (C-18’), 169.6 (C-21’), 168.97 (C-23’), 148.0 (C-4), 
145.23 (C-1,C-10’) , 144.99 (C-9’), 137.2 (C-3’), 134.9 (C-7’), 133.8 (C-6), 132.3 (C-14’), 
131.0 (C-11’), 125.1 (C-2), 123.56 (C-6’), 123.59 (C-5),  121.5 (C-3), 121.0 (C-2’),  120.1, 
39.5 (C-4’), 38.4 (C-8’), 30.9 (C-12’), 28.6 (C-8’), 28.3 (C-5’),  27.6 (C-1’), 27.3 (C-
13’),25.7 (C-15’),20.50 (C-22’), 21.1 (C-22’),  17.6 (C-16’), 16.5 (C-7), 16.1 (C-19’), 15.9 
(C-20’).
1.38 
 
O
COOH
O
O
O
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5.3.4.4 Attempted synthesis of sargachromenol (2.10)    
 
 
 
 
 
 
 
 
Procedure A (Mori et al., 2006) 
 
To a solution of sargaquinoic acid (1.39) (1.2 mg, 0.003 mmol) pyridine, (1.5 mL, 18.6 
mmol) was added. The reaction was stirred at room temperature over night. The reaction 
mixture was acidified with 1 M HCl (10 mL) and extracted with CH2Cl2 (3 mL).The organic 
phase was concentrated under reduced pressure. The 
1
H NMR spectrum of the crude showed 
no formation of sargachromenol. 
 
Procedure B (Kusumi et al., 1979) 
 
A solution of sargaquinoic acid (1.39) (85 mg, 0.2 mmol) dissolved in EtOH (2 mL) and 
water (48 mL) was stirred at room temperature for five days. 5 mL of the reaction mixture 
was extracted with CH2Cl2, concentrated under reduced pressure and analysed by NMR 
during the course of the reaction. All 
1
H NMR spectra showed unreacted starting material.  
 
  
5.3.4.5 Reduction of sargahydroquinoic acid to sargaquinol (5.5)  
 
 
 
 
 
 
 
To a solution of sargahydroquinoic acid (1.38) (140.7 mg, 0.33 mmol) dissolved in 
anhydrous THF (5 mL), LiAlH4 (0.104 g, 2.74 mmol) was added. The reaction mixture was 
stirred at room temperature, under a nitrogen line for 1.25 hours. The crude product was 
extracted with EtOAc (10 mL x 2) and H2O (5 mL). The organic layer was concentrated 
 1.38 
 
COOH
HO
O
1.38 
 
CH2OHO
O
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under reduced pressure to give a crude product which was purified by silica gel 
chromatography (Hexane: EtOAc, 80:20) to give sargaquinol (5.5) (12.2 mg, 30%) and the 
alcohol derivative of sargachromenol (5.6) (2.8 mg, 3.5%). 
Sargaquinol (5.5) yellow oil (30%). 
1
H NMR (400 MHz, CDCl3) δ 6.54 (s, 1H) (H-3), 6.46 
(s, 1H) (H-5), , 5.15 (dd, J = 21.0, 13.2 Hz) (H- 2’, 6’, 14’), 4.11 (s) (H-18’), 3.63 (t, J = 6.5 
Hz) (H-10’), 3.12 (d, J = 7.1 Hz) (H-1’), 2.12 (s) (H-5’, 9’, 13’), 2.05 (s) (H-4’, 8’), 1.67 (s) 
(H- 7, 16’), 1.60 (s) (H-19’, 20’) , 1.57 (s) (H-17’).   
 
13
C NMR (100 MHz, CDCl3) δ 188.0 (C-1), 187.97 (C-4), 148.5 (C-6), 145.9 (C-2), 139.7 
(C-3’), 135.0 (C-7’), 133.1 (C-3), 131,2 (C-11’),  132.24 (C-5), 133.7 (C-15’), 124.7 (C-6’) , 
124.2 (C-14’),  118.1 (C-2’), 71.8 (C-18’), 62.8 (C-10’), 39.8 (C-4’), 39.5 (C-8’), 35.2 (C-
12’), 27.1 (C-13’),27.5 (C-1’), 26.2 (C-5’) , 26.3 (C-9’), 25.6 (C-16’), 17.7 (C-7), 16.11 (C-
17’), 16.07 (C-19’), 15.96 (C-20’). 
 
Sargachromenol alcohol derivative (5.6) yellow oil (3.5%). 
1
H NMR (400 MHz, CDCl3) δ 
6.47 (d, J = 2.4 Hz) (H-5), 6.32 (d, J = 2.5 Hz) (H-2), 6.26 (s) (H-2’), 5.98 (t, J = 7.2 Hz) (H-
9’), 5.57 (d, J = 9.8 Hz) (H-3’), 5.12 (dt, J = 19.0, 6.4 Hz) (H-5’, 14’), 2.59 (q, J = 7.3 Hz (H-
8’), 2.27 (t, J = 7.4 Hz), 2.13 (s) (H-12’), 2.09 – 2.04 (m) (H-4’, 7’), 1.68 (s) (H-8), 1.58 (d, J 
= 3.5 Hz) (H-17’, 19’), 1.36 (s) (20’). 
 
13
C NMR (100 MHz, CDCl3) δ 148.6 (C-5), 144.95 (C-10’), 144.82 (C-8), 134.7 (C-7’), 
131.8 (C-15’), 130.6 (C-11’), 126.3 (C-3), 124.7 (C-6’), 124.1 (C-1’), 122.9 (C-14’), 121.3 
(C-2), 117.0 (C-4), 110.3 (C-6), 77.8 (C-3’), 60.3 (C-18’), 40.7 (C-4’), 39.8 (C-8’), 35.1 (C-
12’), 35.3 (C-12’), 27.0 (C-9’), 26.1 (C-13’), 25.88 (C-20’), 25.67 (C-16’), 22.56 (C-5’), 17.7 
(17’), 15.9 (C-7), 15.5 (C-19’). 
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5.3.4.6 Conversion of sargaquinol (5.5) to Z-sargaquinal (5.7) 
 
 
 
 
 
 
To a solution of sargaquinol (5.5) (37.2 mg, 0.09 mmol) dissolved in anhydrous CH2Cl2 (8 
mL), Dess-Martins Periodinane (107mg, 0.26 mmol) was added. The reaction mixture was 
stirred at room temperature for 2 hours. The reaction was quenched with CH2Cl2 (10 mL) and 
de-ionised water (10 mL). The organic phase was washed with saturated solutions of 
NaHCO3 (10 mL x 3) and Na2S2O3 (10 mL x 3), dried with anhydrous Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by silica gel column 
chromatography (Hexane: EtOAc, 80:20) to give compound 5.7 (42%, 14.9 mg), as a yellow 
oil. 
 Sargaquinal (5.7): 
1
H, 
13
C and 2D NMR data - see table 5.4 
 
 
 
5.3.4.7 Conversion of sargahydroquinoic acid (1.38) to sargalactone (5.8) 
 
 
 
 
 
 
To a solution of sargahydroquinoic acid (1.38) (89.8mg, 0.21 mmol) dissolved in acetone (2 
mL), cyanuric chloride (59.7mg, 0.32 mmol) in acetone (8 mL) was added. To this solution 
triethylamine  (0.5 mL,1.98  mmol) was added. The reaction mixture was stirred at 30°C for 
5hours, filtered and concentrated under reduced pressure. The crude product was purified by 
silica gel column chromatography   (Hexane: EtOAc, 80:20) followed by HPLC (Hexane: 
EtOAc, 85:15) to yield compound (5.8) (4.4 mg, 5%) as a yellow oil. 
Sargalactone (5.8): 
1
H, 
13
C and 2D NMR data - see table 5.5 
UV (EtOH) λmax 202 nm; IR νmax (film) 1366, 1746, 2910cm
-1
; EIMS m/z 407.26 [M-H]
 +
. 
1.38 
 
HO
O
O
Sargaquinol 
       (5.8) 
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O
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5.3.5 Antiplasmodial Assays 
 
Screening for antiplasmodial activity was conducted by Professor Robyn Van Zyl at the 
Department of Pharmacy and Pharmacology, University of the Witwatersrand. All 
compounds were tested in triplicate against the chloroquine-resistant Gambian FCR-3 strain 
of P. falciparum. The in vitro erythrocytic stage of the parasite was maintained using the 
method outlined by Trager and Jensen (1976). The antimalarial activity of the compounds 
was determined using the tritiated hypoxanthine incorporation assay (Desjardins et al. 1979). 
All assays were carried out using untreated parasites and uninfected red blood cells as 
controls. The concentration that inhibited 50% parasite growth (IC50 value) was determined 
from the log sigmoid dose response curve. Quinine was used as the reference antiplasmodial 
agent.  
 
5.3.6 Cytotoxicity Assay 
Screening for cytotoxicity was conducted by Dr. Adrienne Edkins at the Biomedical and 
Biotechnology Research Unit at Rhodes University. All compounds were tested in triplicate 
against MDA-MB-231 breast carcinoma cells. The cytotoxicity of the compounds was 
determined using the WST-1 assay method (Roche). The cells were treated with a range of 
concentrations of the test compounds or vehicle control (DMSO). Cells treated with DMSO 
were considered to represent 100% viability and the viability of cells at each dose was 
represented relative to this value. The concentration resulting in a decrease of cell viability to 
50% was calculated from the linear portion of the dose response curve. 
 
Supplementary information 
 
See attached CD (supplementary information) for 2D NMR data for sarganaphthoquinone 
(5.1), sargahydroquinoic acid methyl ester (5.2), sargaquinoic acid methyl ester (5.3), 
sargaquinol (5.5),   2’E, 6’E, 10’Z – sargaquinal (5.7) and sargalactone (5.8). 
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Conclusion 
The investigation of the chemical differences between S. heterophyllum and S. elegans raised 
interesting questions with respect to the chemical composition of the two species. While this 
project provided preliminary information on the metabolite profiles of the two species, 
further studies involving a higher number of sampled specimens and the separation of crude 
extract components are required to conclusively prove that these species are chemically in- 
distinct.  
Despite the relatively high standard deviations obtained in the comparison of four different 
techniques for the extraction of metabolites from S. heterophyllum, qNMR allowed for simple 
and efficient quantification of analytes extracted by the investigated techniques. However, the 
method presented in this project may be improved by validation in addition to the 
determination of certain parameters such as the upper and lower limits of quantification. It 
would have been useful to compare results obtained from the qNMR study with those 
obtained from gravimetric experiments; however, the rapid oxidation of pure 
sargahydroquinoic acid (1.38) would have presented significant challenges for the accurate 
gravimetric quantification of this metabolite. 
 
Despite the fact that none of the derivatives had significant antiplasmodial activity, this study 
was successful in providing preliminary information on the functional groups that influence 
the antiplasmodial activity of sargahydroquinoic acid (1.38). From the information obtained 
here, several other modifications of 1.38 may be made in an effort to increase the 
antiplasmodial activity of the derivatives synthesised in this project. Such alterations may 
include combining portions of the most active compounds such as methylating the carboxylic 
acid group of sarganaphthoquinone (5.1). In addition to this, the antiplasmodial activity of 
sargahydroquinoic acid derivatives obtained by other alterations to this compound still 
remain to be investigated. Examples of these alterations include the substitution of the 
carboxylic acid moeity with various functional groups such as amides, halides or heterocycles 
or esterifying the hydroxyl functional groups on the hydroquinone moeity of 1.38. The use of 
a natural product (1.38) as the starting material in chemical reactions required extra caution in 
the selection of reaction conditions. Hence, exposure to harsh conditions required to cause 
certain reactions in typical chemical syntheses were generally avoided. The optimisation of 
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reaction conditions as was accomplished for the oxidation of 1.38 to 1.39 may be required to 
successfully complete the reactions which were not successful in the current study.  
 
 
 
 
 
 
